126 results on '"Chen, Yan"'
Search Results
2. Research on Mechanisms of Chinese Medicines in Prevention and Treatment of Postoperative Adhesion
- Author
-
Wang, Ya-li, Zhang, Hui-xiang, Chen, Yan-qi, Yang, Li-li, Li, Zheng-jun, Zhao, Min, Li, Wen-lin, Bian, Yao-yao, and Zeng, Li
- Published
- 2023
- Full Text
- View/download PDF
3. Potential Targets and Signaling Mechanisms of Cinnamaldehyde Enhancing Intestinal Function and Nutritional Regulation in Fat Greenling (Hexagrammos otakii).
- Author
-
Gu, Yixin, Zhan, Yu, Guo, Yafeng, Hua, Wenyuan, Qi, Xin, Gu, Zhizhi, Cao, Shengnan, Chen, Yan, Xue, Zhuang, and Wang, Wei
- Subjects
HEREDITY ,PROSTAGLANDIN receptors ,TRANSCRIPTION factors ,CHINESE medicine ,FAT ,MOLECULAR docking - Abstract
Cinnamaldehyde is an ideal feed additive with good immune enhancement and anti-inflammatory regulation effects. However, the anti-inflammatory regulation mechanism in fat greenling (Hexagrammos otakii, H. otakii) remains unclear. The nine targets of cinnamaldehyde were gathered in identified by the Traditional Chinese Medicine Systems Pharmacology database and Uniprot database, and 1,320 intestinal inflammation disease (IIF)-related proteins were screened from DrugBank, Online Mendelian Inheritance in Man (OMIM), Genecards, and Pharmacogenetics and Pharmacogenomics Knowledge Base (PHARMGKB) Databases. According to the Gene Ontology enrichment results and Kyoto Encyclopedia of Genes and Genomes pathway results, cinnamaldehyde may regulated the responses to bacteria, lipopolysaccharide, an inflammatory cytokine, and external stimuli via the nuclear factor kappa-B (NFκB) signaling pathway within on inflammatory network. In addition, the protein–protein interaction analysis assisted in obtaining the closely related inflammatory regulatory proteins, including the C5a anaphylatoxin chemotactic receptor 1 (C5aR1), transcription factor p65 (RELA), prostaglandin G/H synthase 2 (PTGS2), and toll-like receptor 4 (TLR4), which were confirmed as the bottleneck nodes of the network to be more deeply verified via the molecular docking. Moreover, a cinnamaldehyde feeding model was established for evaluating the anti-inflammatory effect of cinnamaldehyde in vivo. According to the current findings implied that cinnamaldehyde may play a protective role against IIF H. otakii by reducing inflammation through the C5 complement (C5)/C5aR1/interleukin-6 (IL-6) and TLR4/NFκB/PTGS2 pathway. The study focused on investigating the action mechanism of cinnamaldehyde on IIF through combining pharmacology and experimental verification in vivo, which provided a fresh perspective on the promoting effect of cinnamaldehyde on IIF in fish. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Efficacy of Dan'e Fukang Soft Extract in Moderate Ovarian Hyperstimulation Syndrome for Concurrent Treatment of Blood and Fluid Guided by the "Triple Prevention" Principle.
- Author
-
Chen, Yan-Hua, Zhang, Xue-Luo, Li, Zhong-Yun, Wang, Xian-Ping, Wang, Jun, Zhang, Zhi-Ping, Zhu, Peng-Fei, and Wu, Xue-Qing
- Subjects
- *
OVARIAN hyperstimulation syndrome , *DYSMENORRHEA , *OOCYTE retrieval , *EMBRYO transfer , *FERTILIZATION in vitro , *CHINESE medicine - Abstract
This study aimed to evaluate the therapeutic efficacy and safety of Dan'e Fukang soft extracts in moderate ovarian hyperstimulation syndrome (OHSS) for the simultaneous treatment of blood and fluid, guided by the traditional Chinese medicine principle of "triple prevention". Methods: This study conducted a retrospective analysis of clinical data from outpatients who underwent in vitro fertilization (IVF)/intracytoplasmic sperm injection embryo transfer (ICSI-ET). A total of 2245 cases were included and divided into a treatment group (1002 cases) and a control group (1243 cases). Patients in the treatment group were administered Dan'e Fukang soft extracts orally in addition to conventional Western medicine. Comparative assessments were made between the two groups on pelvic ascites volume, maximum ovary diameter, dysmenorrhea incidence post-oocyte retrieval, and safety indicators. Results: There were no statistically significant differences between the treatment group and the control group in terms of general characteristics or the levels of follicle-stimulating hormone (FSH), luteotropic hormone (LH), estradiol (E2), or progesterone (P) at the time of gonadotropin (Gn) initiation. The groups did not differ significantly when we compared the levels of LH, E2, or P on the day of human chorionic gonadotropin (hCG) injection and during ovarian hyperstimulation protocols (P > 0.05 for all indicators). The differences in the volume of pelvic ascites, the maximum ovarian diameter, and the incidence of dysmenorrhea after oocyte retrieval were statistically significant between the treatment group and the control group (P < 0.05 in both). There were no instances of adverse reactions in either group. Conclusion: Based on the traditional Chinese medicine principle of "triple prevention", the use of Dan'e Fukang soft extracts for the simultaneous treatment of blood and fluid in moderate OHSS significantly improved the absorption of pelvic ascites, promoted ovarian recovery, and reduced the incidence of dysmenorrhea after oocyte retrieval. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Ultrasound-Assisted Extraction of Paeonol from Moutan Cortex: Purification and Component Identification of Extract.
- Author
-
Meng, Ling, Chen, Yan, Zheng, Zhenjia, Wang, Lei, Xu, Yahui, Li, Xiujun, Xiao, Zhijian, Tang, Zheng, and Wang, Zhaosheng
- Subjects
- *
TIME-of-flight mass spectrometry , *ETHANOL , *CHINESE medicine , *RESPONSE surfaces (Statistics) , *PHENOLS - Abstract
Moutan Cortex (MC) is a traditional Chinese medicine that contains abundant medicinal components, such as paeonol, paeoniflorin, etc. Paeonol is the main active component of MC. In this study, paeonol was extracted from MC through an ultrasound-assisted extraction process, which is based on single-factor experiments and response surface methodology (RSM). Subsequently, eight macroporous resins of different properties were used to purify paeonol from MC. The main components of the purified extract were identified by ultra-performance liquid chromatography–quadrupole–time of flight–mass spectrometry (UPLC-Q-TOF-MS/MS). The results indicate the optimal parameters are as follows: liquid-to-material ratio 21:1 mL/g, ethanol concentration 62%, ultrasonic time 31 min, ultrasonic temperature 36 °C, ultrasonic power 420 W. Under these extraction conditions, the actual yield of paeonol was 14.01 mg/g. Among the eight tested macroporous resins, HPD-300 macroporous resin was verified to possess the highest adsorption and desorption qualities. The content of paeonol increased from 6.93% (crude extract) to 41.40% (purified extract) after the HPD-300 macroporous resin treatment. A total of five major phenolic compounds and two principal monoterpene glycosides were characterized by comparison with reference compounds. These findings will make a contribution to the isolation and utilization of the active components from MC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Clinical efficacy of a combination treatment of traditional Chinese medicine for scalp seborrheic dermatitis.
- Author
-
Zhang, Fan, Li, Yuan‐hong, Ren, Wei, Li, Shu‐run, and Chen, Yan‐chao
- Subjects
CHINESE medicine ,SEBORRHEIC dermatitis ,ENTERIC-coated tablets ,TREATMENT effectiveness ,SCALP - Abstract
Objective: To evaluate the clinical efficacy of a combination treatment of traditional Chinese medicine (TCM) in scalp seborrheic dermatitis (SSD) of differing severity. Methods: Our study included patients with typical SSD who visited the Medical Research Center for Hair and Skin at our hospital. Symptoms were evaluated using a "16‐point scale" developed at the center. Patients who had mild SSD were treated with Pi Fu Kang Xi Ye (PFKXY), those with moderate SSD were treated with PFKXY combined with Run Zao Zhi Yang Jiao Nang (RZZYJN), and those with severe dermatitis were treated with PFKXY and RZZYJN along with garlicin enteric‐coated tablets. Patients were asked to revisit 4 weeks later to evaluate the efficacy. Results: Symptom scores of all patients decreased by (5.48 ± 2.51) after treatment as compared with before treatment, and the results of t‐test and correlation test were significant (p < 0.01). The scores of patients with mild, moderate and severe SSD decreased by 3.14 ± 1.83, 4.90 ± 1.77, and 8.05 ± 2.21, respectively, after treatment as compared with before treatment. Among them, the changes in scores of patients with moderate dermatitis before and after treatment were significant in the t‐test and correlation test (p < 0.01). Conclusion: In this study, the combination treatment of TCM showed significant efficacy in the treatment of mild, moderate, and severe SSD, and the efficacy was stable, especially for patients with moderate SSD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Protective Effects of Chaihu Shugan San (柴胡疏肝散) on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance
- Author
-
Jiang, Wei-ning, Li, Dan, Jiang, Tao, Guo, Jiao, Chen, Yan-fen, Wang, Jie, Zhou, Yun, Yang, Chao-yan, and Tang, Chun-ping
- Published
- 2018
- Full Text
- View/download PDF
8. In Silico Identification of Natural Product-Based Inhibitors Targeting IL-1β/IL-1R Protein–Protein Interface.
- Author
-
Liu, Ting-ting, Chen, Yan-kun, Adil, Muhammad, Almehmadi, Mazen, Alshabrmi, Fahad M., Allahyani, Mamdouh, Alsaiari, Ahad Amer, Liu, Pei, Khan, Muhammad Raheel, and Peng, Qinghua
- Subjects
- *
DRY eye syndromes , *PROTEIN-ligand interactions , *CHINESE medicine , *MEDICAL screening , *AUTOIMMUNE diseases , *IDENTIFICATION - Abstract
IL-1β mediates inflammation and regulates immune responses, cell proliferation, and differentiation. Dysregulation of IL-1β is linked to inflammatory and autoimmune diseases. Elevated IL-1β levels are found in patients with severe COVID-19, indicating its excessive production may worsen the disease. Also, dry eye disease patients show high IL-1β levels in tears and conjunctival epithelium. Therefore, IL-1β signaling is a potential therapeutic targeting for COVID-19 and aforementioned diseases. No small-molecule IL-1β inhibitor is clinically approved despite efforts. Developing such inhibitors is highly desirable. Herein, a docking-based strategy was used to screen the TCM (Traditional Chinese Medicine) database to identify possible IL-1β inhibitors with desirable pharmacological characteristics by targeting the IL-1β/IL-1R interface. Primarily, the docking-based screening was performed by selecting the crucial residues of IL-1β interface to retrieve the potential compounds. Afterwards, the compounds were shortlisted on the basis of binding scores and significant interactions with the crucial residues of IL-1β. Further, to gain insights into the dynamic behavior of the protein–ligand interactions, MD simulations were performed. The analysis suggests that four selected compounds were stabilized in an IL-1β pocket, possibly blocking the formation of an IL-1β/IL-1R complex. This indicates their potential to interfere with the immune response, making them potential therapeutic agents to investigate further. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Discovery of Novel Chinese Medicine Compounds Targeting 3CL Protease by Virtual Screening and Molecular Dynamics Simulation.
- Author
-
Cheng, Jin, Hao, Yixuan, Shi, Qin, Hou, Guanyu, Wang, Yanan, Wang, Yong, Xiao, Wen, Othman, Joseph, Qi, Junnan, Wang, Yuanqiang, Chen, Yan, and Yu, Guanghua
- Subjects
MOLECULAR dynamics ,MEDICAL screening ,CHINESE medicine ,COVID-19 ,SARS-CoV-2 ,PROTEOLYTIC enzymes - Abstract
The transmission and infectivity of COVID-19 have caused a pandemic that has lasted for several years. This is due to the constantly changing variants and subvariants that have evolved rapidly from SARS-CoV-2. To discover drugs with therapeutic potential for COVID-19, we focused on the 3CL protease (3CL
pro ) of SARS-CoV-2, which has been proven to be an important target for COVID-19 infection. Computational prediction techniques are quick and accurate enough to facilitate the discovery of drugs against the 3CLpro of SARS-CoV-2. In this paper, we used both ligand-based virtual screening and structure-based virtual screening to screen the traditional Chinese medicine small molecules that have the potential to target the 3CLpro of SARS-CoV-2. MD simulations were used to confirm these results for future in vitro testing. MCCS was then used to calculate the normalized free energy of each ligand and the residue energy contribution. As a result, we found ZINC15676170, ZINC09033700, and ZINC12530139 to be the most promising antiviral therapies against the 3CLpro of SARS-CoV-2. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
10. Gancao Nourishing-Yin decoction combined with methotrexate in treatment of aging CIA mice: a study based on DIA proteomic analysis.
- Author
-
Chen, Yong, Zhu, Xing-wang, Lai, Wing-Fu, Liu, Yong-pu, Xu, Xuan-feng, Liu, Li-ming, Chen, Yan-juan, Zhang, Chuan-fu, Wang, Guang-yi, Cheng, Zhi-qiang, and Liu, Dong-zhou
- Subjects
BIOLOGICAL models ,CYTOKINES ,C-reactive protein ,BIOMARKERS ,HERBAL medicine ,COMBINATION drug therapy ,OSTEOCLASTS ,STAINS & staining (Microscopy) ,ANIMAL experimentation ,INFLAMMATION ,SERUM ,METABOLISM ,BLOOD collection ,PROTEOMICS ,METHOTREXATE ,SEVERITY of illness index ,CELLULAR signal transduction ,BIOINFORMATICS ,RHEUMATOID arthritis ,ENZYME-linked immunosorbent assay ,DRUG synergism ,GENOTYPES ,FACTOR analysis ,DESCRIPTIVE statistics ,MASS spectrometry ,RESEARCH funding ,FOLIC acid ,CLUSTER analysis (Statistics) ,DATA analysis software ,CHINESE medicine ,MICE ,PHENOTYPES ,PHARMACODYNAMICS - Abstract
Background: Elderly rheumatoid arthritis (ERA) population faces multiple treatment dilemma. Here we aim to investigate if Gancao Nourishing-Yin decoction (GCNY) added to methotrexate (MTX) exhibit better effects in an ERA mice model. Methods: ERA mice model was established by adding D-galactose (Dgal) to collagen-induced arthritis (CIA) mice. The model was then assigned into control group (CIA + Dgal), MTX treatment group (MTX), GCNY treatment group (GCNY), and integrative treatment group (MTX + GCNY). Pathological scoring was performed to evaluate the severity between the groups. Proteomic analysis was applied to investigate the secretory phenotype of the ERA mouse model and the underlying mechanism of GCNY, MTX and their combination. Representative cytokines related to proteomic results were further validated by ELISAs. Results: CIA + Dgal mice showed more aggressive joints damage than the CIA mice. Besides changes in the inflammatory pathway such as Pi3k-Akt signaling pathway in both model, differential expressed proteins (DEPs) indicated metabolism-related pathways were more obvious in CIA + Dgal mice. Low-dose MTX failed to show pathological improvement in CIA + Dgal mice, while GCNY improved joints damage significantly. Besides down-regulated inflammation-related targets, GCNY-regulated DEPs (such as Apoc1 ~ 3, Grk2 and Creb3l3) were broadly enriched in metabolism-related pathways. MTX + GCNY showed the best therapeutic effect, and the DEPs enriched in a variety of inflammatory,metabolism and osteoclast differentiation signaling pathway. Notably, MTX + GCNY treatment up-regulated Dhfr, Cbr1, Shmt1 involved in folic acid biosynthesis and anti-folate resistance pathways indicated a coincidence synergic action. ELISAs confirmed CPR and Akt that elevated in CIA + Dgal mice were significantly ameliorated by treatments, and adding on GCNY elevated folic acid levels and its regulator Dhfr. Conclusion: Aging aggravated joints damage in CIA, which probably due to metabolic changes rather than more severe inflammation. GCNY showed significant effects in the ERA mice model especially when integrated with MTX to obtain a synergic action. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Inhibitory Effect of Astragalus Polysaccharide on Premetastatic Niche of Lung Cancer through the S1PR1-STAT3 Signaling Pathway.
- Author
-
Shen, Ming, Wang, Yan-jun, Liu, Zhao-hua, Chen, Yan-wen, Liang, Qian-kun, Li, Yang, and Ming, Hai-xia
- Subjects
POLYSACCHARIDES ,BIOLOGICAL models ,HERBAL medicine ,MEDICINAL plants ,ANIMAL experimentation ,LUNG tumors ,METASTASIS ,DISEASES ,CELLULAR signal transduction ,GENE expression ,MYELOID-derived suppressor cells ,DESCRIPTIVE statistics ,ASTRAGALUS (Plants) ,DATA analysis software ,CHINESE medicine - Abstract
As a common malignant tumor, the morbidity and mortality of lung cancer have been rising in recent years. The concept of "premetastatic niche" may lead to a revolutionary change in antitumor metastasis therapeutic strategies. Traditional Chinese medicine with multitargets and lower poisonous agents may be a potentially effective means to intervene in the "premetastatic niche (PMN)" to prevent and treat tumor metastasis. Astragalus polysaccharide (APS) is a substance with strong immune activity in Astragalus membranaceus that has excellent biological activities such as immunomodulation, anti-inflammatory, and antitumor. In this study, we constructed a tumor lung metastasis animal model to explore the intervention mechanism of APS on the premetastatic niche. We found that APS inhibited the formation of the lung premetastatic niche and inhibited the recruitment of myeloid-derived suppressor cells (MDSCs) in the lung. Mechanistically, we showed that the proteins and gene expression of S1PR1, STAT3, and p-STAT3 in the S1PR1/STAT3 signaling pathway were suppressed by APS. In line with the above findings, our results confirmed that APS may inhibit the accumulation of MDSCs in the premetastatic niche through the intervention of the S1PR1-STAT3 signaling pathway to achieve the antitumor effect. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B.
- Author
-
Ji, Dong, Chen, Yan, Bi, Jingfeng, Shang, Qinghua, Liu, Huabao, Wang, Jia-Bo, Tan, Lin, Wang, Jing, Chen, Yongping, Li, Qin, Long, Qinghua, Song, Laicheng, Jiang, Li, Xiao, Guangming, Yu, Zujiang, Chen, Liang, Wang, Xiaodong, Chen, Da, Li, Zhiqin, and Dong, Zheng
- Subjects
- *
CHRONIC hepatitis B , *HEPATITIS B , *CHINESE people , *HEPATOCELLULAR carcinoma , *HEPATIC fibrosis , *CHINESE medicine - Abstract
Chronic hepatitis B (CHB) and liver fibrosis are associated with a high risk of hepatocellular carcinoma (HCC) development. We assessed whether entecavir (ETV) plus Biejia-Ruangan compound (BRC), an anti-fibrotic traditional Chinese medicine, can further reduce the risk of HCC in treatment-naïve Chinese patients with CHB and an Ishak fibrosis score of ≥3 points derived from our parent double-blind randomized placebo-controlled trial. After a 72-week comparison between ETV+BRC and ETV+placebo treatment, participants were eligible to enter an open-label treatment phase and were followed up every 6 months. The primary [secondary] endpoints were the incidence of HCC [liver-related deaths, non-HCC events, and non-liver-related deaths]. Modified intention-to-treat (mITT), intention-to-treat (ITT), and per-protocol (PP) populations were defined for the time-to-event analysis. A total of 1,000 patients were recruited; the median age was 42.0 years; 69.9% were male and 58.3% were HBeAg positive. In the mITT population, the 7-year cumulative incidence of HCC [liver-related deaths] was 4.7% [0.2%] for ETV+BRC, which was significantly lower than 9.3% [2.2%] for ETV monotherapy (p = 0.008 [ p = 0.030]). Notably, ETV+BRC treatment yielded a lower incidence of HCC in those who did not achieve regression of fibrosis at week 72 than ETV monotherapy (p = 0.018). There were no differences in the other 2 secondary endpoints or safety profiles between the groups. Multivariable Cox proportional regression analysis, including the treatment allocation as a parameter, also demonstrated that ETV+BRC treatment was associated with a reduced incidence of HCC. The ITT and PP analyses showed consistent results. ETV plus BRC combination treatment could further reduce the risk of HCC and liver-related deaths in patients with CHB and advanced fibrosis or cirrhosis, which may have important clinical implications for HCC prevention. Patients with chronic hepatitis B virus infection are at an increased risk of developing liver cancer (specifically hepatocellular carcinoma [HCC]). While there are effective antiviral treatments that can suppress the virus in chronically infected patients, the risk of HCC remains. Herein, we show that adding a traditional Chinese medicine called Biejia-Ruangan compound to an antiviral reduced the risk of HCC in patients with chronic hepatitis B. [Display omitted] • This RCT-based prospective cohort study included 1,000 patients and lasted for 7 years. • Compared with ETV treatment, the combination of ETV + Biejia-Ruangan compound could further reduce the incidence of HCC. • Biejia-Ruangan compound in addition to ETV should be considered for patients with CHB and advanced fibrosis or cirrhosis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
13. Integrated dose–response metabolomics with therapeutic effects and adverse reactions may demystify the dosage of traditional Chinese medicine.
- Author
-
Chen, Yan-Yan, Chen, Jia-Qian, Tang, Yu-Ping, Shang, Er-Xin, Zhao, Qi, Zou, Jun-Bo, Xu, Ding-Qiao, Yue, Shi-Jun, Yang, Jie, Fu, Rui-Jia, Zhou, Gui-Sheng, and Duan, Jin-Ao
- Subjects
- *
DRUG efficacy , *HERBAL medicine , *METABOLOMICS , *RHUBARB , *DOSE-effect relationship in pharmacology , *TOXICITY testing , *DESCRIPTIVE statistics , *CHINESE medicine , *METABOLITES , *DRUG administration , *DRUG dosage , *THERAPEUTICS - Abstract
Background: Traditional Chinese medicine (TCM) has been used to treat various diseases for thousands of years. However, the uncertainty of dosage as well as the lack of systemic evaluation of pharmacology and toxicology is one major reason why TCM remains mysterious and is not accepted worldwide. Hence, we aimed to propose an integrated dose–response metabolomics strategy based on both therapeutic effects and adverse reactions to guide the TCM dosage in treatment. Methods: The proposed methodology of integrated dose–response metabolomics includes four steps: dose design, multiple comparison of metabolic features, response calculation and dose–response curve fitting. By comparing the changes of all metabolites under different doses and calculating these changes through superposition, it is possible to characterize the global disturbance and thus describe the overall effect and toxicity of TCM induced by different doses. Rhubarb, commonly used for constipation treatment, was selected as a representative TCM. Results: This developed strategy was successfully applied to rhubarb. The dose–response curves clearly showed the efficacy and adverse reactions of rhubarb at different doses. The rhubarb dose of 0.69 g/kg (corresponding to 7.66 g in clinic) was selected as the optimal dose because it was 90% of the effective dose and three adverse reactions were acceptable in this case. Conclusion: An integrated dose–response metabolomics strategy reflecting both therapeutic effects and adverse reactions was established for the first time, which we believe is helpful to uncover the mysterious veil of TCM dosage. In addition, this strategy benefits the modernization and internationalization of TCM, and broadens the application of metabolomics. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Clinical study on long-term overall survival of advanced non-small-cell lung cancer patients treated with Chinese medicine and western medicine
- Author
-
Chen, Yan-zhi / 陈衍智, Feng, Xiao-bing / 冯小兵, Li, Zhan-dong / 李占东, Zheng, Wen-xian / 郑文献, Sun, Hong / 孙 红, and Li, Ping-ping / 李萍萍
- Published
- 2014
- Full Text
- View/download PDF
15. Deciphering the pharmacological mechanisms of Shenlingbaizhu formula in antibiotic-associated diarrhea treatment: Network pharmacological analysis and experimental validation.
- Author
-
Chen, Yan, Meng, Xiangmei, Zheng, Haocheng, Gu, Yixiao, Zhu, Wanhong, Wang, Sici, Lin, Jie, Li, Tao, Liao, Mengting, Li, Yuhang, Guo, Shuzhen, and Ding, Xia
- Subjects
- *
CHINESE medicine , *ANTIBIOTICS , *DIARRHEA , *IN vitro studies , *COMPUTER-assisted molecular modeling , *HERBAL medicine , *PHARMACEUTICAL chemistry , *CELLULAR signal transduction , *IN vivo studies , *RATS , *GENES , *ANIMAL experimentation , *MASS spectrometry , *RESEARCH methodology , *LIQUID chromatography - Abstract
Shenlingbaizhu (SLBZ) formula, a classical traditional Chinese medicinal (TCM) formula, has been widely used for treating antibiotic-associated diarrhea (AAD). However, the underlying pharmacological mechanisms have not yet been investigated thoroughly. To explore the remission mechanism of SLBZ in the treatment of AAD, we conducted network pharmacological analysis and experimental validation in vitro and in vivo. In this study, the main compounds of SLBZ were identified by ultra-high-performance liquid chromatography-mass spectroscopy (UHPLC-MS) and online databases. The targets of the active components and AAD-related targets were predicted by network pharmacology, and the potential targets of SLBZ against AAD were obtained. Then the core targets were recognized after Protein-Protein Interaction (PPI) analysis. Based on these, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway analyses were conducted, and the key pathway was screened. Subsequently, molecular docking was performed using Auto Dock Vina to find the key components that played a crucial role in that pathway. Molecular dynamics simulation was performed by Gromacs software to detect the binding mode. Finally, the results were confirmed by in vitro and in vivo experiments. A total of 66 active ingredients of SLBZ were detected by UHPLC-MS, and 128 active ingredients were screened out by network pharmacological analysis. Additionally, 935 drug targets and 1686 AAD-related targets were obtained. Seventy-eight intersected genes were selected as potential therapeutic targets and 19 genes were excavated as core targets. Enrichment analysis revealed PI3K-AKT signaling pathway was the key pathway in SLBZ against AAD. Topological analysis further revealed that JAK2, MTOR, TLR4, and SYK were the key targets affected by SLBZ on the PI3K-AKT pathway, and 52 components of SLBZ were associated with them. Molecular docking and dynamics simulation revealed strong binding affinities between MTOR and diosgenin. Subsequently, after SLBZ treatment, the expression levels of JAK2, MTOR, TLR4, and SYK were found significantly upregulated in the AAD model rats (p < 0.05). The cell experiment further validated the good binding ability between MTOR and diosgenin. We demonstrate that the therapeutic effect of SLBZ on AAD was achieved in part by inhibiting the PI3K-AKT pathway. [Display omitted] • Ultra-high-performance liquid chromatography-mass spectroscopy was used to identify the main compounds of Shenlingbaizhu (SLBZ) formula. • Network pharmacology and in vivo experiments showed that the therapeutic effect of SLBZ on antibiotic-associated diarrhea was achieved in part by inhibiting the PI3K/AKT pathway. • This study revealed for the first time that diosgenin in SLBZ was the main ingredient that inhibited the PI3K/AKT pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Modern research thoughts and methods on bio-active components of TCM formulae.
- Author
-
TANG, Yu-Ping, XU, Ding-Qiao, YUE, Shi-Jun, CHEN, Yan-Yan, FU, Rui-Jia, and BAI, Xue
- Abstract
TCM formulae are the important guidances for clinical application of traditional Chinese medicines, which follow the principles of diagnosis and treatment in TCM. Elucidating the bio-active components of TCM formulae is the key to the modernization and internationalization of traditional Chinese medicines. With the rapid development of modern instruments and technology, many new theories, methods and strategies are emerging, which upgrade the research of TCM formulae into a higher level. Only when the medicinal efficacy, bio-active components, function mechanism of TCM formulae are understood, we can guarantee TCM safety and quality control. In this paper, we summarized the latest modern research thoughts and methods on bio-active components of TCM formulae including formula decomposition study, serum pharmacology and serum pharmacochemistry, association analysis, biochromatography, network pharmacology, metabolomics and proteomics, so as to provide reference for the research and development of TCM in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. Pharmacological Activities of Safflower Yellow and Its Clinical Applications.
- Author
-
Chen, Yan, Li, Meifeng, Wen, Jiayu, Pan, Xiaoqi, Deng, Zixin, Chen, Junren, Chen, Guanru, Yu, Lei, Tang, Yunli, Li, Gangmin, Xie, Xiaofang, and Peng, Cheng
- Subjects
- *
CARDIOVASCULAR disease prevention , *CEREBROVASCULAR disease prevention , *HERBAL medicine , *BLOOD circulation , *PLANT extracts , *MOLECULAR structure , *LITERATURE reviews , *HEALTH promotion , *CHINESE medicine ,THERAPEUTIC use of plant extracts - Abstract
Background. Safflower is an annual herb used in traditional Chinese herbal medicine. It consists of the dried flowers of the Compositae plant safflower. It is found in the central inland areas of Asia and is widely cultivated throughout the country. Its resistance to cold weather and droughts and its tolerance and adaptability to salts and alkalis are strong. Safflower has the effect of activating blood circulation, dispersing blood stasis, and relieving pain. A natural pigment named safflower yellow (SY) can be extracted from safflower petals. Chemically, SY is a water-soluble flavonoid and the main active ingredient of safflower. The main chemical constituents, pharmacological properties, and clinical applications of SY are reviewed in this paper, thereby providing a reference for the use of safflower in preventing and treating human diseases. Methods. The literature published in recent years was reviewed, and the main chemical components of SY were identified based on chemical formula and structure. The pharmacological properties of hydroxysafflor yellow A (HSYA), SYA, SYB, and anhydrosafflor yellow B (AHSYB) were reviewed. Results. The main chemical constituents of SY included HSYA, SYA, SYB, and AHSYB. These ingredients have a wide range of pharmacological activities. SY has protective effects on the heart, kidneys, liver, nerves, lungs, and brain. Moreover, its effects include, but are not limited to, improving cardiovascular and cerebrovascular diseases, abirritation, regulating lipids, and treating cancer and diabetic complications. HSYA is widely recognised as an effective ingredient to treat cardiovascular and cerebrovascular diseases. Conclusion. SY has a wide range of pharmacological activities, among which improving cardiovascular and cerebrovascular diseases are the most significant. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Salvianolic Acid B Attenuates Iopromide-Induced Renal Tubular Epithelial Cell Injury by Inhibiting the TLR4/NF-κB/NLRP3 Signaling Pathway.
- Author
-
Pei, Ming Xin, Dong, Shu Jun, Gao, Xin Yue, Luo, Ting, Fan, Dong, Jin, Jun Feng, Zhao, Xiao Duo, and Chen, Yan Ling
- Subjects
THERAPEUTIC use of plant extracts ,STATISTICS ,HERBAL medicine ,MEDICINAL plants ,ANALYSIS of variance ,KIDNEY tubules ,CONTRAST media ,CELL receptors ,APOPTOSIS ,FISHER exact test ,CELLULAR signal transduction ,GENE expression ,MOLECULAR biology ,CELL survival ,EPITHELIAL cells ,PLANT extracts ,BIOLOGICAL assay ,DATA analysis ,CHINESE medicine - Abstract
Postcontrast acute kidney injury (PC-AKI) is directly caused by the use of contrast, indicating a clear causal relationship between the contrast and the injury. Salvianolic acid B (Sal B), a water-soluble compound of Salvia miltiorrhiza, has a potent anti-inflammatory effect. We conducted a study to explore whether the protective effect of Sal B on iopromide-induced injury in human proximal tubular epithelial cells (HK-2 cells) is related to inhibition of the TLR4/NF-κB/NLRP3 signal pathway. The results showed that 100 μmol/L Sal B counteracted the decrease in cell viability, the increase of ROS and the number of apoptotic cells, and the decrease of mitochondrial membrane potential (ΔΨm) induced by iopromide. Molecular docking analysis showed that Sal B binds TLR4 and NLRP3 proteins. Moreover, 100 μmol/L Sal B also decreased the expression of TLR4, NLRP3, ASC, Caspase-1, IL-18, IL-1β, TNF-α, p-NF-κB, cleaved caspase-3, and the ratio of Bax/Bcl-2 induced by iopromide. TAK-242, a TLR4 antagonist, was added to further explore the mechanism of Sal B. However, the cotreatment group with TAK-242 and Sal B had no significant difference in cell viability and apoptosis rate compared to the treatment group with TAK-242 or Sal B alone. These results indicated that Sal B can inhibit the TLR4/NF-κB/NLRP3 signal pathway, resulting in the alleviation of iopromide-induced HK-2 cell injury. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
19. Establishment of a mice model of the yin deficiency pattern of the liver and kidney and the effect of Gouqi Juhua Fang on asthenopia.
- Author
-
HUANG Zhiqiang, ZHANG Jianjun, ZHAO Danping, ZHOU Xue, WANG Chun, CHEN Yan, CHEN Liang, DU Jun, LIU Hongyue, LI Guoyuan, and WANG Linyuan
- Subjects
EYESTRAIN ,ANIMAL disease models ,CYCLIC nucleotides ,IMMUNE serums ,CHINESE medicine ,EPICATECHIN - Abstract
Objective To verify and reveal the mechanism of traditional Chinese medicine (TCM) of Gouqi Juhua Fang (GJ Fang) on asthenopia, this experiment studied the nourishing effect of GJ Fang by establishing the yin deficiency of the liver and kidney pattern model. Methods According to body weight, 50 male Kunming mice were randomly divided into five groups (each n = 10): normal group, model group, Qiju Dihuang Pill (QD Pill) group (3.0 g/kg), low-dose GJ Fang group (65.7 mg/kg), and high-dose GJ Fang group (131.4 mg/kg). Each morning, the intervention groups were administered corresponding medicine by gavage, and the normal group and model group were administered the same amount of distilled water by gavage, for 14 days. Each afternoon, the model group and each intervention group were given levothyroxine sodium solution (150 μg/kg) by gavage, and then the tail was clipped about 3 cm from the tip for 5 minutes, for 14 days. The general state of the mice was observed every day, and all mice were weighed on the 1st, 7th, and 14th day. On the 14th day, the temperature tropism was detected. On the 15th day, all mice were sacrificed, and the samples were collected. The thymus index was calculated; the cyclic nucleotides, thyroid hormones, sex hormones, liver function, and immune factors in serum were detected; the energy metabolism enzyme activities and oxidation levels in the liver tissue were also determined. Results Compared with the normal group, the model group showed symptoms of deficiency and heat such as weight loss, dry and hard stools, yellow urine, increased voluntary activities, irritability, active reactions, and the desire to be close to the cold environment. The symptoms both improved to a certain extent in the QD Pill group and GJ Fang group. Compared with the model group, the low- and high-dose GJ Fang group showed the following: The bodyweight of the mice was increased (P<0.05); the contents of cAMP, cGMP, cAMP/cGMP, E2/T, T4, and ALT were decreased (P < 0.05); the thymus index was increased (P<0.05); and the levels of T3 and IL-2 increased (P<0.05). In addition, the contents of MDA and the activities of Na
+ -+ +-ATPase and Ca2+ -Mg2+ -ATPase decreased (P<0.05) in the liver. Conclusion GJ Fang and QD Pill both can improve internal heat and endocrine hormone disorders in yin deficiency, reduce the rate of energy metabolism, enhance the immunity and antioxidant factors level, and comprehensively relieve the state of yin deficiency in the liver and kidney, thus relieving asthenopia. Because of the safe formula and clear active ingredients, GJ Fang has the potential to be developed into a safe, stable, controllable, and pattern-differentiated product for asthenopia. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
20. Effects of Processing Method Changes in Main Volatile Compounds of Qixue Shuangbu Prescription by Needle Trap Device Coupled with Gas Chromatography-Triple Quadrupole Mass Spectrometry.
- Author
-
Chen, Linwei, Jiang, Yong, Liu, Lunyuan, Bei, Chenqi, Chen, Yan, Wang, Hua, Tian, Hu, Chen, Ziduan, and Wang, Qin
- Subjects
GAS chromatography/Mass spectrometry (GC-MS) ,QUADRUPOLE ion trap mass spectrometry ,MASS spectrometry ,QUADRUPOLES ,CHINESE medicine ,MEDICAL prescriptions - Abstract
Qixue Shuangbu Prescription (QSP) has been widely applied in the treatment of chronic heart failure (CHF). Previous clinical studies have found that the efficacy of processed QSP was significantly enhanced in the treatment of CHF. We have identified and analyzed the nonvolatile components before and after processing of QSP, and predicted the mechanism of synergistic effect after processing in the treatment of CHF. However, the synergistic mechanism of processed QSP caused by the difference of volatile components was still unclear. In this study, we developed a method of needle trap device coupled with gas chromatography-triple quadrupole mass spectrometry to elucidate the difference of volatile components between crude and processed QSP. The established method has been used to identify 104 volatile compounds in crude and processed QSP. The results of multivariate data showed 38 differential compounds were screened as potential markers, which would further explain the mechanism of processing synergistic effect of processed QSP. This study successfully developed the method to elucidate its processing mechanism based on the difference of volatile compositions between crude and processed QSP for the first time, and it would provide a novel analytical strategy for the impacts of different processing methods on main volatile compounds in traditional Chinese medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
21. Effects of combined Chinese drugs and chemotherapy in treating advanced non-small cell lung cancer
- Author
-
Chen, Yan-zhi / 陈衍智, Li, Zhan-dong / 李占东, Gao, Fei / 高 非, Zhang, ying / 张 莹, Sun, Hong / 孙 红, and Li, Ping-ping / 李萍萍
- Published
- 2009
- Full Text
- View/download PDF
22. Multicenter clinical study on the treatment of children’s tic disorder with Qufeng Zhidong Recipe (祛风止动方)
- Author
-
Wu, Min / 吴 敏, Xiao, Guang-hua / 肖光华, Yao, Min / 姚 敏, Zhang, Jian-ming / 张建明, Zhang, Xin / 张 欣, Zhou, Ya-bing / 周亚兵, Zhang, Jing-yan / 张婧延, Wang, Shu-xia / 王树霞, Ma, Bo / 马 博, and Chen, Yan-ping / 陈燕萍
- Published
- 2009
- Full Text
- View/download PDF
23. Fuzzy identification of bioactive components for different efficacies of rhubarb by the back propagation neural network association analysis of UPLC-Q-TOF/MSE and integrated effects.
- Author
-
Chen, Jia-Qian, Chen, Yan-Yan, Du, Xia, Tao, Hui-Juan, Pu, Zong-Jin, Shi, Xu-Qin, Yue, Shi-Jun, Zhou, Gui-Sheng, Shang, Er-Xin, Tang, Yu-Ping, and Duan, Jin-Ao
- Subjects
- *
ORGANIC compound analysis , *POLYMER analysis , *PHENOL analysis , *DRUG efficacy , *QUINONE , *HIGH performance liquid chromatography , *GLYCOSIDES , *TANNINS , *RHUBARB , *MASS spectrometry , *ARTIFICIAL neural networks , *CHROMONES , *CHINESE medicine , *FLAVANONES - Abstract
Background: Rhei Radix et Rhizoma (rhubarb), as one of the typical representatives of multi-effect traditional Chinese medicines (TCMs), has been utilized in the treatment of various diseases due to its multicomponent nature. However, there are few systematic investigations for the corresponding effect of individual components in rhubarb. Hence, we aimed to develop a novel strategy to fuzzily identify bioactive components for different efficacies of rhubarb by the back propagation (BP) neural network association analysis of ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry for every data (UPLC-Q-TOF/MSE) and integrated effects. Methods: Through applying the fuzzy chemical identification, most components of rhubarb were classified into different chemical groups. Meanwhile the integration effect values of different efficacies can be determined by animal experiment evaluation and multi-attribute comprehensive indexes. Then the BP neural network was employed for association analysis of components and different efficacies by correlating the component contents determined from UPLC-Q-TOF/MSE profiling and the integration effect values. Finally, the effect contribution of one type of components may be totaled to demonstrate the universal and individual characters for different efficacies of rhubarb. Results: It suggested that combined anthraquinones, flavanols and their polymers may be the universal character to the multi-functional properties of rhubarb. Other components contributed to the individuality of rhubarb efficacies, including stilbene glycosides, anthranones and their dimers, free anthraquinones, chromones, gallic acid and gallotannins, butyrylbenzenes and their glycosides. Conclusions: Our findings demonstrated that the bioactive components for different efficacies of rhubarb were not exactly the same and can be systematically differentiated by the network-oriented strategy. These efforts will advance our knowledge and understanding of the bioactive components in rhubarb and provide scientific evidence to support the expansion of its use in clinical applications and the further development of some products based on this medicinal herb. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
24. Molecular Mechanism of Salvia miltiorrhiza Bunge in Treating Cerebral Infarction.
- Author
-
Ye, Xietao, Liu, Jiali, Yuan, Xinyao, Yang, Songhong, Huang, Yi, and Chen, Yan
- Subjects
LIPID metabolism ,DRUG efficacy ,INTERLEUKINS ,HERBAL medicine ,CEREBRAL infarction ,EPIDERMAL growth factor ,MOLECULAR biology ,TREATMENT effectiveness ,CELLULAR signal transduction ,DATA analysis software ,COMPUTER-assisted molecular modeling ,CHINESE medicine ,THERAPEUTICS - Abstract
Background. Cerebral infarction (CI) is a common brain disease in clinical practice, which is mainly due to the pathological environment of ischemia and hypoxia caused by difficult cerebral circulation perfusion function, resulting in ischemic necrosis of local brain tissue and neurological impairment. In traditional Chinese medicine (TCM) theory, CI is mainly due to blood stasis in the brain. Therefore, blood-activating and stasis-dissipating drugs are often used to treat CI in clinical practice. Salvia miltiorrhiza Bunge (SMB) is a kind of traditional Chinese medicine with good efficacy in promoting blood circulation and removing blood stasis, and treatment of CI with it is a feasible strategy. Based on the above analysis, we chose network pharmacology to investigate the feasibility of SMB in the treatment of CI and to study the possible molecular mechanisms by providing some reference for the treatment of CI with TCM. Methods. The active ingredients and related targets of SMB were obtained through the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database, and CI-related targets were obtained from the GeneCards and DisGeNET databases. The target of SMB for the treatment of CI was obtained using Cytoscape software and visualized. GO and KEGG enrichment analysis was performed based on "clusterProfiler" within R, and the prediction results were validated by molecular docking technique. Results. By constructing a compound-target (C-T) network, it was found that the active components in SMB mainly treated CI by regulating key proteins such as AKT1, IL-6, and EGFR. These key proteins mainly involve in pathways such as immune regulation, cancer and lipid metabolism, such as lipid and atherosclerosis, chemical carcinogenesis-receptor activation pathways, and IL-17 signaling pathway. In the GO term, it mainly regulates the response to steroid hormones, membrane rafts, and G protein-amine receptor coupled activity. Eventually, we verified that the luteolin and tanshinone IIA components in SMB have a good possibility of action with AKT1 and IL-6 by in silico techniques, indicating that SMB has some scientificity in the treatment of CI. Conclusion. SMB mainly treats CI by regulating 94 proteins involved in lipid and atherosclerosis, chemical carcinogenesis-receptor activation, and IL-17 signaling pathway. Our research strategy provided a template for the drug development of TCM for the treatment of CI. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
25. Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
- Author
-
Rong, Guanghua, Chen, Yongping, Yu, Zujiang, Li, Qin, Bi, Jingfeng, Tan, Lin, Xiang, Dedong, Shang, Qinghua, Lei, Chunliang, Chen, Liang, Hu, Xiaoyu, Wang, Jing, Liu, Huabao, Lu, Wei, Chen, Yan, Dong, Zheng, Bai, Wenlin, Yoshida, Eric M, Mendez-Sanchez, Nahum, and Hu, Ke-Qin
- Subjects
CHRONIC hepatitis B ,HEPATIC fibrosis ,CLINICAL trial registries ,FIBROSIS ,CHINESE medicine ,RESEARCH ,PURINES ,RESEARCH methodology ,ARTHRITIS Impact Measurement Scales ,CIRRHOSIS of the liver ,ANTIVIRAL agents ,EVALUATION research ,TREATMENT effectiveness ,COMPARATIVE studies ,DISEASE complications - Abstract
Background: Long-term nucleos(t)ide analogue (NA) treatment can reverse liver fibrosis in chronic hepatitis B (CHB), but its effect on fibrosis regression remains limited. Biejia-Ruangan (BR) has been approved in China as an antifibrotic traditional Chinese medicine drug in patients with chronic liver diseases. A multicenter randomized controlled trial aims to evaluate the effect of BR on fibrosis regression in CHB patients treated with NAs.Methods: CHB patients with histologically confirmed advanced fibrosis or cirrhosis were randomly assigned to receive entecavir (ETV) (0.5 mg per day) plus BR (2 g 3 times a day) or placebo for 72 weeks. Liver fibrosis regression was defined as a reduction of ≥ 1 point by the Ishak fibrosis stage (IFS).Results: Overall, 500 patients were enrolled in each group as the intention-to-treat population. The rate of fibrosis regression after 72 weeks of treatment was significantly higher in the ETV + BR group (40% vs 31.8%; P = .0069). Among 388 patients with cirrhosis (ie, IFS ≥ 5) at baseline, the rate of cirrhosis reversal (ie, IFS ≤ 4) was significantly higher in the ETV + BR group (41.5% vs 30.7%; P = .0103).Conclusions: Addition of BR to the current standard treatment with NAs in CHB patients with advanced fibrosis or cirrhosis can improve liver fibrosis regression.Clinical Trials Registration: NCT01965418. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
26. Scutellaria barbata Inhibits Hepatocellular Carcinoma Tumorigenicity by Inducing Ferroptosis of Hepatocellular Carcinoma Cells.
- Author
-
Li, Yue, Zhang, Jiongshan, Zhang, Kun, Chen, Yan, Wang, Wei, Chen, Hongjie, Zou, Zengcheng, Li, Yongwei, and Dai, Min
- Subjects
HEPATOCELLULAR carcinoma ,SCUTELLARIA ,CHINESE medicine ,MITOCHONDRIAL membranes ,LIPID metabolism - Abstract
Ferroptosis is caused by accumulation of iron-dependent lipid peroxidation, which is characterized by reduction in cell volume and increase in mitochondrial membrane density. Studies have shown that ferroptosis contributes to the development and progression of numerous major diseases, including hepatocellular carcinoma (HCC). As a unique biomedical resource, Traditional Chinese Medicine (TCM) has been widely used in the treatment of HCC. In this present study, Scutellaria barbata was used to treat HCC cells in vitro , and the results revealed that S. barbata suppressed HCC cell growth through inducing ferroptosis. Next, the exploration of the molecular mechanism on how S. barbata induced ferroptosis in HCC cells suggested that S. barbata may induce ferroptosis by promoting iron perioxidation and lipid ROS metabolism. Finally, S. barbata also inhibited HCC tumorigenicity in vivo by inducing ferroptosis of HCC cells. These results provided theoretical basis for explaining the mechanism of TCM treatment for HCC and offered therapeutic opportunities for HCC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. Network Pharmacology-Based Analysis on the Curative Effect of Kunxian Capsules against Rheumatoid Arthritis.
- Author
-
Yan, Hong-Xia, Xu, Chun-Fang, Yang, Hong, Wen, Xiao-Ya, Wang, Zhi-Peng, Chen, Yan-Hong, Liu, Jing-Xue, Chen, Wan-Sheng, Gao, Shou-Hong, and Tao, Xia
- Subjects
HERBAL medicine ,HIGH performance liquid chromatography ,PHARMACOLOGY ,RHEUMATOID arthritis ,MASS spectrometry ,PLANT extracts ,CHINESE medicine - Abstract
Kunxian capsules (KCs), a Chinese patent medicine, have been clinically proven to be effective in the treatment of rheumatoid arthritis (RA). However, the chemical profile of KC remains to be characterized, and the mechanism underlying the protective effect against RA is yet to be elucidated. Here, a network pharmacology-based approach was adopted, integrated with the chemical profiling of KC by UHPLC-Q-TOF/MS. As a result, a total of 67 compounds have been identified from KC extract, among which 43 were authenticated by comparison to the mass spectrum of standard chemicals. ADME behaviors of the chemical constituents of KC were predicted, resulting in 35 putative active ingredients. Through target prediction of both active ingredients of KC and RA and PPI analysis, core targets were screened out, followed by biological process and related pathway enrichment. Then, a TCM-herb-ingredient-target-pathway network was constructed and a multicomponent, multitarget, and multipathway synergistic mechanism was proposed, providing an information basis for further investigation. The active pharmaceutical ingredients included mainly terpenoids (such as triptolide and celastrol), sesquiterpene pyridines (such as wilforgine and wilforine), and flavonoids (such as icariin, epimedin A, B, and C, and 2″-O-rhamnosylicariside II). [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
28. Exploration of the Potential Mechanism of Tao Hong Si Wu Decoction for the Treatment of Breast Cancer Based on Network Pharmacology and In Vitro Experimental Verification.
- Author
-
Huang, Shi, Chen, Yan, Pan, Lingyu, Fei, Changyi, Wang, Ni, Chu, Furui, Peng, Daiyin, Duan, Xianchun, and Wang, Yongzhong
- Subjects
BREAST cancer ,INHIBITION of cellular proliferation ,BRCA genes ,CANCER treatment ,CHINESE medicine - Abstract
Background: Tao Hong Si Wu Decoction (THSWD) is a well-known traditional Chinese medicine used clinically alone or combined with drugs to treat breast cancer. However, there has been no study to date on the underlying mechanisms of its therapeutic effects. Objectives: To explore the potential mechanism of THSWD for the treatment of breast cancer using network pharmacology and experimental research. Methods: The active ingredients of THSWD were screened according to Lipinski's rule of five based on the 107 ingredients of THSWD identified by UPLC-Q-TOF-MS
E . The targets of THSWD and breast cancer from multiple databases were collected, and a Compound-Target-Pathway network based on protein-protein interaction (PPI) was constructed. Gene ontology (GO) analysis and KEGG pathway analysis were performed via the DAVID server. Molecular docking studies verified the selected key ingredients and key targets. The results of network pharmacology were verified by in vitro experiments. Including the effects of THSWD drug-containing rat serum (THSWD serum) on cell proliferation, and on the targets HRAS, MAPK1, AKT1, GRB2, and MAPK14 were assayed by RT-qPCR and Western blot assays. Results: In total, 27 active ingredients including 8 core components, were obtained from 107 ingredients and 218 THSWD target genes for the treatment of breast cancer were identified. THSWD is active in the treatment of breast cancer by targeting Ras, FoxO, PI3K-Akt and other signaling pathways. MCF-7 and MDA-MB-231 cell proliferation was inhibited by THSWD serum in a time and concentration dependent manner. THSWD could regulated the RNA and protein expression of core targets HRAS, MAPK1, AKT1, GRB2, and MAPK14 for treatment of breast cancer. Conclusion: The results of network pharmacology study showed that THSWD is active against breast cancer by intervening with multiple targets and pathways. Luteolin, kaempferol, senkyunolide E, and other 8 compounds may be the core active ingredients of THSWD in the treatment of breast cancer. THSWD treatment of breast cancer may be related to targeting Ras, FoxO, PI3K-Akt, and other signal pathways associated with the core targets HRAS, MAPK1, AKT1, GRB2, and MAPK14. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
29. Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat.
- Author
-
Lan, Qingping, Ren, Zhitao, Chen, Yan, Cui, Guozhen, Choi, I. Cheong, Ung, Carolina Oi Lam, Yu, Hon Ho, and Lee, Simon Ming-Yuen
- Subjects
LIPID analysis ,PROTEIN metabolism ,BIOLOGICAL models ,HERBAL medicine ,GASTRIC intubation ,NON-alcoholic fatty liver disease ,ANIMAL experimentation ,INFLAMMATION ,DIET ,METHIONINE ,RATS ,CHOLINE ,DIETARY supplements ,MESSENGER RNA ,TRANSCRIPTION factors ,CHINESE medicine ,ALANINE aminotransferase ,ASPARTATE aminotransferase ,PHOSPHORYLATION - Abstract
Background: Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD) for which there is yet any standard pharmacotherapy. Traditional Chinese medicine formula such as Qushihuayu (QSHY) composing of multiple bioactive compounds has been used to treat NAFLD and NASH and shows beneficial effects over single compound treatment. This study aimed to investigate the mechanism of hepatoprotective effect of QSHY formula using a rat model. Methods: Six-weeks old male Wistar rats were given methionine/choline supplemented (MCS) diet for 8 weeks and used as the blank control. Another 7 rats, which received methionine/choline deficient (MCD) diet in the first 6 weeks and a MCS&MCD (1:1) mixture diet in the last 2 weeks, were used as the model group. The groups of QSHY pre-treatment, low dosage, medium dosage and high dosage were given the same diet as the model group. Except for pre-treatment group (1 week in advanced of other groups), all QSHY treatment groups received QSHY formula by gavage every day since the MCD diet started. Results: In the MCD diet group, the QSHY formula decreased the serum ALT and AST levels, lipid droplets, inflammation foci, FAS and α-SMA protein expression than MCD diet group. MAPK pathways phospharylation were markedly depressed by the QSHY formula. Moreover, QSHY formula enhanced PPAR-γ and p-p65 translocating into nucleus. The administration of QSHY increased hepatic mRNA levels of Transcription Factor 1 alpha (HNF1A), Hepatocyte Nuclear Factor 4 alpha (HNF4A) and Forkhead box protein A3 (FOXA3) which play a pivotal role in Hepatic stellate cell (HSCs) reprogramming. Conclusion: These findings suggest that QSHY formula exerts a hepatoprotective effect against steatosis and fibrosis presumably via depressed MAPK pathways phosphorylation, reinforcement of PPAR-γ and p-p65 translocating into nucleus and enhanced HSCs reprogramming. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
30. Constructing the Logical Regression Model to Predict the Target of Jianpi Jiedu Decoction in the Treatment of Hepatocellular Carcinoma.
- Author
-
Zhang, Rongjie, Chen, Yan, Zhou, Ge, Sun, Baoguo, Li, Yue, and Chen, Zexiong
- Subjects
- *
THERAPEUTIC use of antineoplastic agents , *THERAPEUTIC use of monoclonal antibodies , *TISSUE analysis , *APOPTOSIS , *CITRATES , *GENES , *GENETIC techniques , *HEPATOCELLULAR carcinoma , *HERBAL medicine , *CHINESE medicine , *RISK assessment , *STATISTICS , *SURVIVAL analysis (Biometry) , *TRANSCRIPTION factors , *LOGISTIC regression analysis , *BIBLIOGRAPHIC databases , *PROPORTIONAL hazards models , *STATISTICAL models , *DESCRIPTIVE statistics , *DISEASE risk factors , *THERAPEUTICS - Abstract
Objectives. The purpose of this study was to identify the molecular mechanism and prognosis-related genes of Jianpi Jiedu decoction in the treatment of hepatocellular carcinoma. Methods. The gene expression data of hepatocellular carcinoma samples and normal tissue samples were downloaded from TCGA database, and the potential targets of drug composition of Jianpi Jiedu decoction were obtained from TCMSP database. The genes were screened out in order to obtain the expression of these target genes in patients with hepatocellular carcinoma. The differential expression of target genes was analyzed by R software, and the genes related to prognosis were screened by univariate Cox regression analysis. Then, the LASSO model was constructed for risk assessment and survival analysis between different risk groups. At the same time, independent prognostic analysis, GSEA analysis, and prognostic analysis of single gene in patients with hepatocellular carcinoma were performed. Results. 174 compounds of traditional Chinese medicine were screened by TCMSP database, corresponding to 122 potential targets. 39 upregulated genes and 9 downregulated genes were screened out. A total of 20 candidate prognostic related genes were screened out by univariate Cox analysis, of which 12 prognostic genes were involved in the construction of the LASSO regression model. There was a significant difference in survival time between the high-risk group and low-risk group (p < 0.05). Among the genes related to prognosis, the expression levels of CCNB1, NQO1, NUF2, and CHEK1 were high in tumor tissues (p < 0.05). Survival analysis showed that the high expression levels of these four genes were significantly correlated with poor prognosis of HCC (p < 0.05). GSEA analysis showed that the main KEGG enrichment pathways were lysine degradation, folate carbon pool, citrate cycle, and transcription factors. Conclusions. In the study, we found that therapy target genes of Jianpi Jiedu decoction were mainly involved in metabolism and apoptosis in hepatocellular carcinoma, and there was a close relationship between the prognosis of hepatocellular carcinoma and the genes of CCNB1, NQO1, NUF2, and CHEK1. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
31. Panax Notoginseng Saponins Prevent Bone Loss by Promoting Angiogenesis in an Osteoporotic Mouse Model.
- Author
-
Hu, Hao, Chen, Yan, Zou, Zhiyuan, Li, Liangping, Wei, Fuxin, Liu, Chun, Ling, Zemin, and Zou, Xuenong
- Subjects
- *
OSTEOPOROSIS prevention , *TISSUE analysis , *ANIMAL experimentation , *BIOMARKERS , *BONES , *BONE growth , *HERBAL medicine , *HISTOLOGICAL techniques , *CHINESE medicine , *MICE , *ORAL drug administration , *OSTEOPOROSIS , *OVARIECTOMY , *OSTEOCALCIN , *DRUG administration , *DRUG dosage - Abstract
With the aging of the population and the extension of life expectancy, osteoporosis is becoming a global epidemic. Although there are several drugs used to treat osteoporosis in clinical practice, such as parathyroid hormone or bisphosphonates, they all have some serious side effects. Therefore, a safer drug is called for osteoporosis, especially for the prevention in the early stage of the disease, not only the treatment in the later stage. Panax notoginseng saponin (PNS), a traditional Chinese herb, has been used as anti-ischemic drug due to its function on improving vascular circulation. In order to verify whether Panax notoginseng saponins (PNS) could be used to prevent osteoporosis, ovariectomy (OVX) was induced in female C57BL/C6J mice, followed by orally administration with 40 mg/kg/d, 80 mg/kg/d, and 160 mg/kg/d of three different dosages of PNS for 9 weeks. Serum biochemical analysis, micro-CT, histological evaluation, and immunostaining of markers of osteogenesis and angiogenesis were performed in the sham, osteoporotic (OVX), and treatment (OVX+PNS) groups. Micro-CT and histological evaluation showed that compared to sham group, the bone mass of OVX group reduced significantly, while it was significantly restored in the moderate-dose PNS (40 mg/kg and 80 mg/kg) treatment groups. The expression of CD31 and osteocalcin (OCN) in the bone tissue of treatment group also increased, suggesting that PNS activated osteogenesis and angiogenesis, which subsequently increased the bone mass. These results confirmed the potential function of PNS on the prevention of osteoporosis. However, in the high dose of PNS (160 mg/kg) group, the antiosteoportic effect had been eliminated, which also suggested the importance of proper dose of PNS for the prevention and treatment of osteoporosis in postmenopausal women. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
32. Efficacy and Safety of Chinese Herbal Formula Granules in Treating Chronic Kidney Disease Stage 3: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
- Author
-
Zhao, Jing, Sun, Wei, Chen, Jihong, Sun, Zhuxing, Chen, Dai, Cao, Chunhua, Yang, Min, Ma, Jipei, Wang, Ling, Xing, Changying, Chen, Yan, Sheng, Meixiao, Zhou, Enchao, Xu, Lingdong, Gao, Kun, Liu, Lihua, Liu, Qiong, Yi, Lan, He, Weiming, and Zhu, Yuanyuan
- Subjects
CHRONIC kidney failure ,HERBAL medicine ,LONGITUDINAL method ,MEDICAL cooperation ,CHINESE medicine ,RESEARCH ,STATISTICAL sampling ,DRUG development ,RANDOMIZED controlled trials ,TREATMENT effectiveness ,BLIND experiment ,DESCRIPTIVE statistics - Abstract
Background. It is generally considered that traditional Chinese medicine (TCM) therapy postpones the progression of some chronic kidney diseases (CKDs). Chinese medicine herbs are widely applied in TCM therapy. We aimed to evaluate clinical efficacy and safety of Chinese herbal formula granules in patients with CKD stage 3 through a prospective randomized controlled study. Methods. A total of 343 participants with CKD stage 3 were recruited from 9 hospitals in Jiangsu Province between April 2014 and October 2016. Participants were randomly assigned to a treatment or control group. Patients in the treatment group orally took Chinese herbal formula granules twice a day, while controls received placebo granules. The duration of intervention was 24 weeks. Primary outcomes were 24-hour proteinuria, serum creatinine, and eGFR, which were measured every 4 weeks. Results. There was no statistical difference in 24-hour proteinuria between the two groups (0.97 ± 1.14 g/d vs. 0.97 ± 1.25 g/d). Patients in the treatment group had significantly lower serum creatinine level (130.78 ± 32.55 μmol/L versus 149.12 ± 41.27 μmol/L) and significantly higher eGFR level (55.74 ± 50.82 ml/min/1.73·m
2 versus 44.46 ± 12.60 ml/min/1.73·m2 ) than those in the control group (P < 0.05). There was no significant difference between two groups in the incidence of adverse events. Conclusion. The treatment adopting Chinese herbal formula granules for 24 weeks improved kidney function of patients with CKD stage 3. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
33. Effects of a Chinese Patent Medicine Gushen'antai Pills on Ongoing Pregnancy Rate of Hormone Therapy FET Cycles: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
- Author
-
Cao, Xian-ling, Song, Jing-yan, Zhang, Xing-xing, Chen, Yan-hua, Teng, Yi-li, Liu, Hai-ping, Deng, Tai-you, and Sun, Zhen-gao
- Subjects
CHINESE medicine ,HORMONE therapy ,CLINICAL trials ,PILLS ,UTERINE hemorrhage ,FERTILIZATION in vitro ,CANCER hormone therapy - Abstract
In the past decade, the number of frozen-thawed embryo transfer (FET) has increased dramatically with the expansion of surgical indications and the improvement of freezing related technologies. How to improve the success rate and reduce the adverse effects of FET is our research priorities. This study aimed to investigate the safety and effectiveness of Gushen'antai pills (GSATP) by measuring the ongoing pregnancy rate (OPR) in patients from FET and hormone therapy (HT) cycle. From November 2019 to May 2020, 5 Chinese hospitals conducted a multi-center, randomized, double-blind, placebo-controlled study. In total, 271 HT FET cycles in patients were randomly divided (1:1 ratio) to receive GSATP (6 g, tid) or placebo (6g, tid) for 12 weeks of pregnancy. Patients, clinicians, and researchers were blinded to treatment allocation. The primary endpoint was the OPR at week 12 of pregnancy. The secondary endpoints were vaginal bleeding or brown discharge rate, implantation rate (IR), clinical pregnancy rate (CPR) and abortion rate (AR). Adverse events were recorded during the treatment period. The results showed that the OPR remained higher in the GSATP group when compared to placebo group (56.62% vs. 44.44%, p = 0.045). Vaginal bleeding or brown discharge rate was lower in the GSATP group than the placebo group (10% vs. 23.08%, p = 0.032), while the IR (35.16% vs. 27.64%, p = 0.070), CPR (58.82% vs. 48.15%, p = 0.078), incidence of total adverse events (8.09% vs. 3.22%, p = 0.051) and AR (3.75% vs. 7.69%, p = 0.504) were similar between GSATP and placebo groups. Subgroup analysis showed that there were significant differences in CPR (74.19% vs. 54.17%, p = 0.004) and OPR (72.04% vs. 51.04%, p = 0.003) between GSATP group and Placebo group when the patient was younger than 35 years old. This multi-center, randomized, double-blinded, placebo-controlled clinical study showed for the first evidence that GSATP may have potential to improve the OPR and decrease vaginal bleeding or brown discharge rate in HT FET cycle patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
34. Comparatively Evaluating the Role of Herb Pairs Containing Angelicae Sinensis Radix in Xin-Sheng-Hua Granule by Withdrawal Analysis.
- Author
-
Pang, Han-Qing, Xu, Ding-Qiao, Tang, Yu-Ping, Zhou, Gui-Sheng, Xu, Hui-Qin, Jin, Yi, Zhu, Zhen-Hua, Shi, Xu-Qin, Yue, Shi-Jun, Chen, Yan-Yan, Huang, Sheng-Liang, and Duan, Jin-Ao
- Subjects
ADENOSINE triphosphatase ,ANIMAL experimentation ,APLASTIC anemia ,BIOLOGICAL models ,FACTOR analysis ,HEMATOPOIETIC agents ,HEMOLYTIC anemia ,HERBAL medicine ,HIGH performance liquid chromatography ,MEDICINAL plants ,CHINESE medicine ,MICE ,MOLECULAR structure ,ORGANIC compounds ,CYCLOPHOSPHAMIDE ,THERAPEUTICS - Abstract
The present study aims to investigate the roles of herb pairs containing Angelicae Sinensis Radix (Danggui) in Xin-Sheng-Hua Granule (XSHG) on hemolytic and aplastic anemia (HAA) mice. HAA model mice were induced by acetyl phenylhydrazine and cyclophosphamide; then the samples of XSHG and its decomposed recipes (DY, DC, DT, DH, DJ, and DZ) were orally administrated to these mice. Indicators of peripheral blood routine, organ index, and ATPase activities were tested. Moreover, the main effective components in these samples were also analyzed by UHPLC-TQ-MS/MS. Clear separation between the control and model groups from score plot of principal component analysis (PCA) was easily seen, indicating that HAA model was successfully conducted. Afterwards, relative distance calculation method between dose groups and control group from PCA score plot was adopted to evaluate the integrated effects of hematinic function of different samples. And the orders of hematinic effects were as follows: XHSG > DJ > DT > DZ > DH > DC > DY. Further analysis of these samples by UHPLC-TQ-MS/MS revealed that XSHG underwent complicated changes when herb pairs containing Danggui were excluded from XSHG, respectively. Compared with XSHG, the vast majority of active compounds in sample DY (formula minus herb pair Danggui-Yimucao) decreased significantly, which could partly explain why herb pair Danggui-Yimucao made great contribution to XSHG. These findings showed that withdrawal analysis method is a valuable tool to analyze the impacts of herb pairs containing Danggui on XSHG, which could lay foundation to reveal the compatibility rules of this formula. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
35. Qiju Dihuang Decoction for Hypertension: A Systematic Review and Meta-Analysis.
- Author
-
Zhang, Shuo, Bai, Xue, Chen, Zhen-Lin, Li, Jia-Jia, Chen, Yan-Yan, and Tang, Yu-Ping
- Subjects
BLOOD pressure ,ENDOTHELINS ,HERBAL medicine ,HYPERTENSION ,INFLAMMATION ,INFORMATION storage & retrieval systems ,MEDICAL databases ,INSULIN resistance ,KIDNEY function tests ,CHINESE medicine ,META-analysis ,MOLECULAR structure ,QUALITY of life ,SYSTEMATIC reviews ,TREATMENT effectiveness ,DATA analysis software ,THERAPEUTICS - Abstract
Objective. To systematically evaluate the efficacy of Chinese herbal medicine Qiju Dihuang Decoction (QDD) for hypertension. Methods. A comprehensive literature search of randomized controlled trials using QDD to treat hypertension was conducted in 7 electronic databases, including Chinese databases. Subjects and abstracts of the trials were read in NoteExpress for preliminary screening, and the full text was read for further screening. The data extraction table was made for the selected 19 trials, and risk of bias was assessed by using the Cochrane collaboration tool, followed by data analysis using Rev Man 5.3. Results. The antihypertensive efficacy of QDD is 1.45 times that of antihypertensive drugs and 1.56 times that of conventional therapies, which can also reduce the endothelin level. QPAD exhibits an antihypertensive effect, and its clinical efficacy is 1.34 times and 1.61 times that of antihypertensive drugs, which can not only significantly lower the diastolic blood pressure but also reduce the 24 h mean ambulate blood pressure. At the same time, it can decrease the TCM syndrome score, inhibit the inflammation, protect the renal function, reduce the insulin resistance, and improve the life quality of patients. Conclusion. QDD can effectively reduce blood pressure and improve the life quality of patients with hypertension, which plays a certain role in preventing hypertension complications. However, due to the methodological deficiencies, more rigorous randomized controlled trials will be needed in the future to provide stronger evidence. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
36. Coloclyster of Red Peony Root Granules Alleviates Moderately Severe Acute Pancreatitis: A Double-Blinded, Placebo-Controlled, Randomized Clinical Trial.
- Author
-
Yang, Fangyong, Qi, Xiuzhong, Du, Yiqi, Chen, Yan, Wang, Meitang, Huang, Haitao, Zhu, Dezeng, Yue, Xiaoqiang, and Wang, Lina
- Subjects
ABDOMINAL pain ,COMPUTED tomography ,DEFECATION ,FEVER ,HERBAL medicine ,INTERLEUKINS ,LYMPHOCYTES ,CHINESE medicine ,NEUTROPHILS ,PANCREATITIS ,PLANT roots ,STATISTICAL sampling ,TUMOR necrosis factors ,RANDOMIZED controlled trials ,TREATMENT effectiveness ,DISEASE remission ,BLIND experiment ,SEVERITY of illness index ,ACUTE diseases ,DRUG administration ,DRUG dosage - Abstract
The red peony root derived from Paeonia lactiflora has been applied to treat human inflammatory diseases. To investigate its therapeutic potential in treating moderately severe acute pancreatitis (MSAP), which has been rarely studied, this study was designed as a double-blinded, placebo-controlled, randomized clinical trial. A total of 60 MSAP patients were enrolled and randomly divided into an experimental (n = 30) group and a control group (n = 30), who received a coloclyster of 15 g of red peony root or placebo granules dissolved in 150 mL of water, respectively. The patients' demographic and clinical characteristics were recorded. The results showed that the experimental group had a shorter remission time of fever (p < 0.05) and abdominal pain (p < 0.01) and faster resumption of self-defecation (p < 0.01) than did the control group. In addition, the coloclyster of red peony root decreased the modified Balthazar CT score as well as the serum interleukin-6 and tumor necrosis factor-alpha levels to a greater extent than did the placebo coloclyster (p < 0.05). The remission times for the normalization of white blood cells and percentage of neutrophils and lymphocytes in the experimental group were also significantly shorter than those in the control group (p < 0.05). In conclusion, a coloclyster of red peony root could help alleviate the clinical symptoms and shorten the course of MSAP by possibly attenuating systematic inflammation. This trial is registered with 14004664. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
37. Meta analysis of clinical efficacy of combination of traditional Chinese and western medicine in the treatment of venous ulcer of lower extremities.
- Author
-
Shi-Meng Yan, Xiao-Ming Hu, Qiang Han, Chen-Yan Shi, Ling Wang, and Guo-Bin Liu
- Subjects
CHINESE medicine ,DRUG efficacy ,VENOUS valves ,ULCER treatment ,LEG diseases ,META-analysis - Abstract
Objective: To test the therapeutic effect of integrated traditional Chinese and western medicine on venous ulcer of lower limbs by Meta analysis method, and then to propose the best clinical treatment scheme. Methods: Domestic databases in the past 20 years (January 1999-December 2019) were searched by computer, including China Journal Full-text Database (CNKI), VIP, Wanfang and CBM. Literature was screened according to inclusion and exclusion criteria. Cochrane risk assessment tool was used to evaluate the quality of the included literature. Two-classification method was used to extract data. RevMan 5.3 software was used to make statistical analysis of the data. Results: Eleven articles were finally included, totaling 1,576 patients, 804 cases in the treatment group and 772 cases in the control group. Meta-analysis results show that there is no difference in heterogeneity and bias among the included literatures. The total effective rate (risk ratio [RR]=1.12, 95% confidence interval [CI]=1.09-1.15) of integrated traditional Chinese and western medicine in treating venous ulcer of lower limbs is higher, which is obviously better than that of western medicine alone. Conclusion: Through data analysis, it is concluded that in the study population, the treatment of integrated traditional Chinese and western medicine has a significant effect on venous ulcer of lower limbs. Make up for the deficiency of simple western medicine treatment, improve the cure rate and reduce the recurrence rate. However, there is currently a lack of relevant high-quality literature, so a large sample size, rigorous and standardized experimental design and randomized double-blind clinical study are needed to further test the conclusions. [ABSTRACT FROM AUTHOR]
- Published
- 2020
38. Deciphering the Active Compounds and Mechanisms of Qixuehe Capsule on Qi Stagnation and Blood Stasis Syndrome: A Network Pharmacology Study.
- Author
-
Huang, Yu-Xi, Xu, Ding-Qiao, Yue, Shi-Jun, Chen, Yan-Yan, Tao, Hui-Juan, Fu, Rui-jia, Xing, Li-Ming, Wang, Taiyi, Ma, Yu-ling, Wang, Bao-An, Tang, Yu-Ping, and Duan, Jin-Ao
- Subjects
ANALYSIS of variance ,ANIMAL experimentation ,CELLULAR signal transduction ,DISCRIMINANT analysis ,FIBRINOGEN ,HERBAL medicine ,CHINESE medicine ,MENSTRUATION disorders ,ORGANIC compounds ,PHARMACOLOGY ,RATS ,DATA analysis software ,DESCRIPTIVE statistics ,PARTIAL thromboplastin time ,PROTHROMBIN time ,THERAPEUTICS - Abstract
Background. Qixuehe capsule (QXH), a Chinese patent medicine, has been demonstrated to be effective in the treatment of menstrual disorders. In traditional Chinese medicine (TCM) theory, qi stagnation and blood stasis syndrome (QS-BSS) is the main syndrome type of menstrual disorders. However, the pharmacodynamic effect of QXH in treating QS-BSS is not clear, and the main active compounds and underlying mechanisms remain unknown. Methods. A rat model of QS-BSS was established to evaluate the pharmacodynamic effect of QXH. Thereafter, a network pharmacology approach was performed to decipher the active compounds and underlying mechanisms of QXH. Results. QXH could significantly reduce the rising whole blood viscosity (WBV) and plasma viscosity (PV) but also normalize prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), and fibrinogen (FIB) content in QS-BSS rats. Based on partial least-squares-discriminant analysis (PLS-DA), the low-dose QXH-intervened (QXH-L) and the high-dose QXH-intervened (QXH-H) groups seemed the most effective by calculating the relative distance to normality. Through network pharmacology, QXH may improve hemorheological abnormality mainly via 185 compounds-51 targets-28 pathways, whereas 184 compounds-68 targets-28 pathways were associated with QXH in improving coagulopathy. Subsequently, 25 active compounds of QXH were verified by UPLC-Q/TOF-MS. Furthermore, 174 active compounds of QXH were shared in improving hemorheological abnormality and coagulopathy in QS-BSS, each of which can act on multiple targets to be mainly involved in complement and coagulation cascades, leukocyte transendothelial migration, PPAR signaling pathway, VEGF signaling pathway, and arachidonic acid metabolism. The attribution of active compounds indicated that Angelicae Sinensis Radix (DG), Paeoniae Radix Rubra (CS), Carthami Flos (HH), Persicae Semen (TR), and Corydalis Rhizoma (YHS) were the vital herbs of QXH in treating QS-BSS. Conclusion. QXH can improve the hemorheology abnormality and coagulopathy of QS-BSS, which may result from the synergy of multiple compounds, targets, and pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
39. Elucidating the interaction of kansui and licorice by comparative plasma/tissue metabolomics and a heatmap with relative fold change.
- Author
-
Chen, Yan-Yan, Shen, Juan, Tang, Yu-Ping, Yu, Jin-Gao, Wang, Jing, Yue, Shi-Jun, Yang, Jie, Chen, Jia-Qian, Feng, Li-Mei, Zhu, Zhen-Hua, Tao, Wei-Wei, Zhang, Li, and Duan, Jin-Ao
- Subjects
METABOLOMICS ,ACETOACETIC acid ,CHINESE medicine ,LINOLEIC acid ,ARACHIDONIC acid - Abstract
Although compatibility is highly advocated in traditional Chinese medicine (TCM), inappropriate combination of some herbs may reduce the therapeutic action and even produce toxic effects. Kansui and licorice, one of TCM " Eighteen Incompatible Medicaments ", are the most representative cases of improper herbal combination, which may still be applied simultaneously under given conditions. However, the potential mechanism of their compatibility and incompatibility is unclear. In the present study, two different ratios of kansui and licorice, representing their compatibility and incompatibility respectively, were designed to elucidate their interaction by comparative plasma/tissue metabolomics and a heatmap with relative fold change. As a result, glycocholic acid, prostaglandin F2a, dihydroceramide and sphinganine were screened out as the principal alternative biomarkers of compatibility group; sphinganine, dihydroceramide, arachidonic acid, leukotriene B4, acetoacetic acid and linoleic acid were those of incompatibility group. Based on the values of biomarkers in each tissue, the liver was identified as the compatible target organ, while the heart, liver, and kidney were the incompatible target organs. Furthermore, important pathways for compatibility and incompatibility were also constructed. These results help us to better understand and utilize the two herbs, and the study was the first to reveal some innate characters of herbs related to TCM " Eighteen Incompatible Medicaments ". Image 1 • Comparative metabolomics was employed to dissect the compatibility and incompatibility mechanism of kansui and licorice. • An interactive heatmap with relative fold change was created to explore complex metabolomics data of herb-herb interaction. • The study first revealed some innate important characters of herbs related TCM " Eighteen Incompatible Medicaments ". [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
40. Ginkgo biloba and Its Constituent 6-hydroxykynurenic-acid as well as Its Proanthocyanidins Exert Neurorestorative Effects against Cerebral Ischemia.
- Author
-
Yao, Jianbiao, Qiao, Hongxiang, Jin, Zhuming, Wang, Ruwei, Huang, Haibo, Fang, Ling, Chen, Yan, Tai, Khalid, Doeppner, Thorsten Roland, Chen, Zhong, and Kuchta, Kenny
- Subjects
ANIMAL experimentation ,BRAIN ,CEREBRAL ischemia ,COMPARATIVE studies ,FLAVONOIDS ,GINKGO ,HERBAL medicine ,LEAVES ,CHINESE medicine ,NEURONS ,NIMODIPINE ,PLACEBOS ,QUINOLINE ,RATS ,SUPEROXIDE dismutase ,TANNINS ,TISSUES ,MALONDIALDEHYDE ,TREATMENT effectiveness ,NEUROPROTECTIVE agents ,GRAPE seed extract ,DRUG administration ,DRUG dosage ,PHARMACODYNAMICS - Abstract
Neuroprotective effects against cerebral ischemia/reperfusion (I/R) injury by Ginkgo biloba leaves are commonly attributed to the antioxidant activity of its proanthocyanidins. Furthermore, preliminary experiments identified 6-hydroxykynurenic acid (6-HKA) as a major contributor to this effect of extract of G. biloba leaves (EGb) prepared according to the Chinese Pharmacopoeia (ChP). In order to elucidate the specific contribution of both proanthocyanidins and 6-HKA to the overall neurorestorative effects of this extract according to ChP, EGb ChP was separated into pure 6-HKA and a newly developed Ginkgo proanthocyanidin extract (GPE), enriched in proanthocyanidins but not containing 6-HKA. Male Sprague-Dawley rats were divided into the groups: sham: 8; model (placebo): 25; GPE 80 mg/kg: 13; GPE 40 mg/kg: 13; GPE 20 mg/kg: 16; grape seed extract (negative control) 40 mg/kg: 18; nimodipine (positive control) 2 mg/kg: 8. All non-sham animals were subjected to cerebral I/R injury by occluding the middle cerebral artery with a nylon suture that was removed after 2 h of ischemia to establish reperfusion. For comparison, a parallel series of experiments were performed with 6-HKA. In these in vivo experiments, neurological dysfunctions were reduced by both GPE and 6-HKA, and both average infarct size and concentrations of malondialdehyde (MDA) and super oxide dismutase (SOD) were significantly ameliorated as compared to the model group. This data, therefore, demonstrates that the neuroprotective effects of EGb cannot be explained by a purely chemical antioxidative effect alone as has been previously proposed, especially with regards to the proanthocyanidins. A pharmacological neurorestorative effect of EGb on neurons and brain tissue itself seems to be a much more straightforward explanation for the presented observations. This effect is most likely explained by the synergistic action of both its numerous phenolic constituents (GPE) and 6-hydroxykynurenic acid (6-HKA), which could be identified as one major contributor to the observed activity. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
41. Hepatoprotective Effect of Jianpi Huoxue Formula on Nonalcoholic Fatty Liver Disease Induced by Methionine-Choline-Deficient Diet in Rat.
- Author
-
Feng, Yu, Chen, Yan, Yang, Binrui, Lan, Qingping, Wang, Tao, Cui, Guozhen, Ren, Zhitao, Choi, I. Cheong, Leung, George Pak-Heng, Yan, Fenggen, Chen, Dacan, Yu, Hon Ho, and Lee, Simon Ming Yuen
- Subjects
- *
FATTY liver prevention , *ANIMAL experimentation , *APOPTOSIS , *ASPARTATE aminotransferase , *CHOLESTEROL , *CHOLINE , *COLLAGEN , *DIET , *HERBAL medicine , *HISTOLOGICAL techniques , *INFLAMMATION , *LIPIDS , *LIVER , *LIVER diseases , *CHINESE medicine , *METHIONINE , *ORAL drug administration , *RATS , *STAINS & staining (Microscopy) , *TRIGLYCERIDES , *TUMOR necrosis factors , *VITAMIN B deficiency , *SYMPTOMS , *FIBROSIS , *ALANINE aminotransferase , *CASPASES , *MATRIX metalloproteinases , *DRUG administration , *DRUG dosage - Abstract
In parallel with the prevalence metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease in most countries. It features a constellation of simple steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and even hepatocellular carcinoma. There are no approved drugs for effective management of NAFLD and NASH. Jianpi Huoxue formula (JPHX) mainly consists of Atractylodes macrocephal (Baizhu), Salvia miltiorrhiza (Danshen), Rasux Paeonia Alba (Baishao), Rhizoma Alismatis (Zexie), and Fructus Schisandrae Chinensis (Wuweizi), which may have beneficial effects on NAFLD. The aim of the study was to identify the effect of JPHX on NAFLD. A NAFLD model was induced by methionine-choline-deficient food (MCD) in Wistar rats and orally administered with simultaneous JPHX, once a day for 8 weeks. Hepatocellular injury, lipid profile, inflammation, fibrosis, and apoptosis were evaluated. The results showed that JPHX significantly decreased the abnormal serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels compared with the MCD model (P<0.05). Furthermore, JPHX protected MCD diet-fed rats from accumulation of hepatic triglycerides (TG) and total cholesterol (TC). Histological examination demonstrated that JPHX noticeably normalized the NAFLD activity score (NAS). Moreover, JPHX ameliorated liver inflammation by decreasing TNF-α levels and reduced collagen and matrix metalloproteinases in MCD diet-fed rats. In addition, JPHX prevented rats from MCD-induced cellular apoptosis, as suggested by TUNEL staining, and suppressed the activation of caspase 3 and 7 proteins. JPHX also inhibited the phosphorylation of JNK. In conclusion, JPHX exhibited a hepatoprotective effect against NAFLD in an MCD experimental model. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
42. Incompatibility assessment of Genkwa Flos and Glycyrrhizae Radix et Rhizoma with biochemical, histopathological and metabonomic approach.
- Author
-
Chen, Yan-Yan, Tang, Yu-Ping, Shang, Er-Xin, Zhu, Zhen-Hua, Tao, Wei-Wei, Yu, Jin-Gao, Feng, Li-Mei, Yang, Jie, Wang, Jing, Su, Shu-Lan, Zhou, Huiping, and Duan, Jin-Ao
- Subjects
- *
LIPID metabolism , *PHENYLALANINE metabolism , *TRYPTOPHAN metabolism , *TYROSINE metabolism , *ANIMAL experimentation , *BIOMARKERS , *BIOCHEMISTRY , *BLOOD testing , *CARDIOTOXICITY , *CLINICAL drug trials , *HEPATOTOXICOLOGY , *HERBAL medicine , *HISTOLOGICAL techniques , *INCOMPATIBLES (Pharmacy) , *PHENOMENOLOGY , *CHINESE medicine , *METABOLISM , *NEPHROTOXICOLOGY , *PHOSPHOLIPIDS , *RATS , *PLANT roots , *TESTIS , *URINALYSIS , *METABOLOMICS , *DRUG administration , *DRUG dosage - Abstract
Abstract Ethnopharmacological relevance As recorded in traditional Chinese medicine (TCM) theory, Genkwa Flos (YH) and Glycyrrhizae Radix et Rhizoma (GC) compose one herbal pair of the so-called "eighteen incompatible medicaments", which indicate pairs of herbs that are mutually incompatible and that theoretically should not be applied simultaneously. However, the theory has been called into question due to a lack of evidence. Aims of study In this study, the incompatibility of YH and GC was investigated based on an assessment of the toxic effects of their combination by traditional safety methods and a modern metabonomic approach. Materials and methods Sprague-Dawley rats were used to evaluate the subacute toxicity of YH and YH-GC. The serum, urine, and several tissues were collected for biochemical analysis, histopathological examination, and metabonomic analysis. Results Rats exposed to a dose of 1.0 g/kg YH (3 times of the Chinese Pharmacopoeia maximum dose) exhibited toxicity of the heart, liver, kidney and testes, and rats exposed to a YH-GC combination (1.0 g/kg YH + 1.0 g/kg GC) exhibited similar hepatotoxicity, which aggravated renal and reproductive toxicity. Following this, a metabonomic study tentatively identified 14 potential biomarkers in the YH group and 10 potential biomarkers in the YH-GC group, and metabolic pathways were then constructed. YH disturbed the pathways of glycerophospholipid metabolism, primary bile acid biosynthesis, and sphingolipid metabolism, while YH-GC combination induced disruptions in phenylalanine, tyrosine and tryptophan biosynthesis, tyrosine metabolism, and glycerophospholipid metabolism. Conclusion The toxicities of YH and YH-GC combination above the Chinese Pharmacopoeia dose were obvious but different. Metabonomics combined with biochemical and histopathological methods can be applied to elucidate the toxicity mechanism of the YH-GC combination that caused liver, kidney and reproductive injuries in rats. Graphical abstract fx1 [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
43. Screening Five Qi-Tonifying Herbs on M2 Phenotype Macrophages.
- Author
-
Jiang, Yi-Xin, Chen, Yan, Yang, Yue, Chen, Xiao-Xia, and Zhang, Dan-Dan
- Subjects
- *
ANIMAL experimentation , *ASTRAGALUS (Plants) , *BREAST tumors , *CELL receptors , *DRUG design , *CLINICAL drug trials , *ETHANOL , *FLAVONOIDS , *FUNGI , *GENE expression , *GINSENG , *GLYCOPROTEINS , *GLYCOSIDES , *GLYCYRRHIZA , *HERBAL medicine , *HYDROLASES , *INTERLEUKINS , *MACROPHAGES , *CHINESE medicine , *MICE , *OXIDOREDUCTASES , *PHOSPHORYLATION , *TUMOR markers , *PHENOTYPES , *HEXOSES - Abstract
Tumor-associated macrophages (TAMs) with M2 phenotype play an essential role in tumor microenvironment (TME) during the progression and development of numerous cancers and associated with poor prognosis. Thus, regulation of TAMs polarization emerged as a new strategy for tumor immune therapy. According to Traditional Chinese Medicine (TCM) theory, herbs with Qi-tonifying character are involved in improving the defense capacity of immune system. In this study, we screened extracts and ingredients from five Qi-tonifying herbs exhibiting an inhibitory effect on M2 polarization of murine macrophages RAW264.7 induced by IL-4 and IL-13. Among these candidates, total flavonoids from Glycyrrhiza Radix et Rhizoma (TFRG) and ethanol extract of Ginseng Radix et Rhizoma significantly inhibited the expression of Arginase-1 (Arg-1) (above 90% at 100μg/mL), one of the phenotype markers of M2 macrophages. The inhibition of total saponins of Ginseng Radix et Rhizoma, ethanol extract of Cordyceps, ethanol extract of Acanthopanacis senticosi Radix et Rhizoma Seu caulis, and ethanol extract of Astragali Radix reached above 50% at 100μg/mL. The inhibition of ingredients including glabridin, isoliquiritin apioside, lysionotin, cordycepin, astragaloside IV, and calycosin reached above 50% at 50μM. Then, we investigated the molecular mechanisms of TFRG. TFRG abolished the migration of murine breast cancer 4T1 stimulated by the conditioned medium from M2 macrophages (M2-CM). In addition to Arg-1, TFRG also antagonized the IL-4/13-mediated mRNA upregulation of the M2 markers including found in inflammatory zone 1 (FIZZ1), chitinase-3-like protein 3 (YM1), and mannose receptor (CD206) and upregulated the expression of inducible nitric oxide synthase (iNOS), one of the M1 markers. The further exploration showed that TFRG decreased the phosphorylation of STAT6 and increased the expression of miR-155. Our study provides a series of potential immune regulating natural products from five Qi-tonifying herbs on M2 phenotype. For instance, TFRG suppressed M2 polarization of macrophages partly by inactivating STAT6 pathway and enhanced the level of miR-155 to regulate the expressions of M1 and M2 markers. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
44. Shugan Liangxue Decoction (舒肝凉血方) Down-Regulates Estrogen Receptor α Expression in Breast Cancer Cells.
- Author
-
Zhou, Ning, Han, Shu-yan, Chen, Yan-zhi, Zhou, Fei, Zheng, Wen-xian, and Li, Ping-ping
- Subjects
CELL proliferation ,BIOLOGICAL assay ,BREAST tumors ,CELL lines ,ESTROGEN receptors ,FLUORESCENT antibody technique ,GENE expression ,HERBAL medicine ,CHINESE medicine ,WESTERN immunoblotting ,PLANT extracts ,DRUG administration ,DRUG dosage - Abstract
Objective: To observe the effect of Shugan Liangxue Decoction (舒肝凉血方, SGLXD) on estrogen receptor α (ERα) in human breast cancer cells.Methods: The effect of SGLXD (0.85-5.10 mg/mL) on the proliferation of breast cancer cells were evaluated by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assay. The nuclear ERα protein levels in MCF-7, T47D and ZR-75-1 cells which treated by SGLXD for 24 h were examined by western blot and immunofluorescence assay. MCF-7 and MDA-MB-231 cells were treated by 17β-estradiol (E2) with or without SGLXD, for 24 h, and the E2 targeted genes c-myc and bcl-2 protein product was evaluated by western blot.Results: SGLXD showed dose-dependent inhibition on the proliferation of MCF-7, T47D and ZR-75-1 cells, but did not inhibit the proliferation of MDA-MB-231 cells. Furthermore, the promotive effect on cell growth induced by E2 was also significantly inhibited by SGLXD treatment. With the treatment of 1.70, 3.40, 5.10 mg/mL SGLXD, the nuclear ERα protein level was reduced to 88.1%, 70.4% and 60.9% in MCF-7 cells, and was decreased to 43.0%, 38.4% and 5.9% in ZR-75-1 cells as compared with the control group. In T47D cells, the nuclear ERα protein was down-regulated to 51.3% and 4.3% by 3.40 and 5.10 mg/mL SGLXD treatment. The down-regulative effect of SGLXD on nuclear ERα was confirmed by immunofluorescence assay. SGLXD decreased the protein product of c-myc and bcl-2.Conclusions: SGLXD may exhibit selective inhibition effect on the proliferation of ER positive breast cancer cells. SGLXD reduced the nuclear ERα expression and the protein product of E2 target gene c-myc and bcl-2. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
45. A three-dimensional integration strategy for Q-markers identification: Taken Euphorbia Pekinensis Radix as an example.
- Author
-
Zeng, Xiao-Tao, Chen, Yan-Yan, Yue, Shi-Jun, Xu, Ding-Qiao, Fu, Rui-Jia, Jie-Yang, and Tang, Yu-Ping
- Subjects
- *
EUPHORBIA , *CHINESE medicine , *QUALITY control , *QUALITY standards - Abstract
Euphorbia Pekinensis Radix (EPR) is an important antitumor medicinal resource. However, quality control of EPR has not been well established due to the lack of quality markers (Q-markers) research. In this study, a three-dimensional integration strategy was developed to systematically characterize Q-markers and this method was successfully applied to identify Q-markers of EPR. Firstly, three core quality attributes-effectiveness, testability and specificity-were considered as three dimensions, and the weights of each dimension were calculated by analytical hierarch process. Then, the values of each dimension were evaluated by multi-indicators. For EPR with antitumor activity, cytotoxic assay and network pharmacology, UPLC analysis and literature search, compound belonging search were employed to calculate the values of effectiveness, testability and specificity, respectively. Finally, the weights and values were multiplied as the scores of each component on that dimension, and the total scores of the three dimensions were further integrated based on the radar plot and expressed as regression area, by which Q-markers were quantified and visualized. Five components were identified as Q-markers of EPR due to their high-ranked antitumor capacity, ease of measurement and excellent specificity, which laid an important foundation for the quality control improvement of EPR. Furthermore, the integrated strategy summarized here is helpful for the quantitative identification of Q-markers and promote the quality standard of traditional Chinese medicine. • A three-dimensional integration strategy was developed to characterize Q-markers. • Effectiveness, testability and specificity were integrated to identify Q-markers. • AHP was used to define the importance of core attributes on Q-markers. • Q-markers of EPR show antitumor effect, easy measurement and specificity property. • Five components were screened out as Q-markers of EPR. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Discovery of Potential Orthosteric and Allosteric Antagonists of P2Y1R from Chinese Herbs by Molecular Simulation Methods.
- Author
-
Zhang, Xu, Lu, Fang, Chen, Yan-kun, Luo, Gang-gang, Jiang, Lu-di, Qiao, Lian-sheng, Zhang, Yan-ling, and Xiang, Yu-hong
- Subjects
THERAPEUTIC use of fibrinolytic agents ,THROMBOSIS prevention ,CHINESE medicine ,ALTERNATIVE medicine ,BLOOD platelet aggregation ,CELL receptors ,HERBAL medicine ,MOLECULAR biology ,RESEARCH funding ,EVIDENCE-based medicine ,BIOINFORMATICS - Abstract
P2Y1 receptor (P2Y1R), which belongs to G protein-coupled receptors (GPCRs), is an important target in ADP-induced platelet aggregation. The crystal structure of P2Y1R has been solved recently, which revealed orthosteric and allosteric ligand-binding sites with the details of ligand-protein binding modes. And it suggests that P2Y1R antagonists, which recognize two distinct sites, could potentially provide an efficacious and safe antithrombotic profile. In present paper, 2D similarity search, pharmacophore based screening, and molecular docking were used to explore the potential natural P2Y1R antagonists. 2D similarity search was used to classify orthosteric and allosteric antagonists of P2Y1R. Based on the result, pharmacophore models were constructed and validated by the test set. Optimal models were selected to discover potential P2Y1R antagonists of orthosteric and allosteric sites from Traditional Chinese Medicine (TCM). And the hits were filtered by Lipinski’s rule. Then molecular docking was used to refine the results of pharmacophore based screening and analyze the binding mode of the hits and P2Y1R. Finally, two orthosteric and one allosteric potential compounds were obtained, which might be used in future P2Y1R antagonists design. This work provides a reliable guide for discovering natural P2Y1R antagonists acting on two distinct sites from TCM. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
47. The Chinese Herb Jianpijiedu Contributes to the Regulation of OATP1B2 and ABCC2 in a Rat Model of Orthotopic Transplantation Liver Cancer Pretreated with Food Restriction and Diarrhea.
- Author
-
Sun, Baoguo, Chen, Yan, Xiang, Ting, Zhang, Lei, Chen, Zexiong, Zhang, Shijun, Zhou, Houming, and Chen, Shuqing
- Subjects
- *
ANIMAL experimentation , *ANTHROPOMETRY , *CARRIER proteins , *DIARRHEA , *GENE expression , *HERBAL medicine , *INGESTION , *LIVER , *LIVER transplantation , *LIVER tumors , *CHINESE medicine , *RATS , *RNA , *SURVIVAL , *MEMBRANE transport proteins , *DRUG administration , *DRUG dosage , *SYMPTOMS - Abstract
Traditional Chinese Medicine Jianpijiedu decoction (JPJD) could improve the general status of liver cancer patients in clinics, especially the symptoms of decreased food intake and diarrhea. In this study, our results showed that the survival rate of the liver cancer with food restriction and diarrhea (FRD-LC) rats was lower than the liver cancer (LC) rats, and the tumor volume of the FRD-LC rats was higher than the LC rats. It was also shown that the high dose of JPJD significantly improved the survival rate, weight, and organ weight when compared with FRD-LC-induced rats. Moreover, JPJD administration upregulated the mRNA and protein levels of ABCC2 and downregulated the mRNA and protein levels of OATP1B2 in liver tissues. However, opposite results were observed in the cancer tissues. In conclusion, the study indicated that the Chinese Medicine JPJD could contribute to the rats with liver cancer which were pretreated with food restriction and diarrhea by regulating the expression of ABCC2 and OATP1B2 in liver tissues and cancer tissues. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
48. Variations of Tongue Coating Microbiota in Patients with Gastric Cancer.
- Author
-
Hu, Jie, Han, Shuwen, Chen, Yan, and Ji, Zhaoning
- Subjects
ACADEMIC medical centers ,BACTERIA ,CHI-squared test ,FISHER exact test ,HEALTH status indicators ,CHINESE medicine ,POLYMERASE chain reaction ,RESEARCH funding ,STOMACH tumors ,T-test (Statistics) ,TONGUE ,CASE-control method ,DESCRIPTIVE statistics ,SEQUENCE analysis - Abstract
The physical status of humans can be estimated by observing the appearance of the tongue coating, known as tongue diagnosis. The goals of this study were to reveal the relationship between tongue coating appearance and the oral microbiota in patients with gastric cancer and to open a novel research direction supporting tongue diagnosis. We used a tongue manifestation acquisition instrument to analyse the thickness of the tongue coating of patients with gastric cancer and that of healthy controls, and high-throughput sequencing was used to describe the microbial community of the tongue coating by sequencing the V2-V4 region of the 16S rDNA. The tongue coatings of 74 patients with gastric cancer were significantly thicker than those of 72 healthy controls (343.11 ± 198.22 versus 98.42 ± 48.25, P < 0.001); 51.35% of the patients were assessed as having thick tongue coatings, whereas all healthy controls were assessed as having thin tongue coatings. Thick tongue coatings presented lower microbial community diversity than thin tongue coatings. The tongue coating bacterial community is associated with the appearance of the tongue coating. The tongue coating may be a potential source for diagnosing gastric cancer, but its sensitivity needs to be further improved. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
49. Jianpi Huayu Decoction Inhibits Proliferation in Human Colorectal Cancer Cells (SW480) by Inducing G0/G1-Phase Cell Cycle Arrest and Apoptosis.
- Author
-
Xi, Song-yang, Teng, Yu-hao, Chen, Yan, Li, Jie-ping, Zhang, Ying-ying, Liu, Shen-lin, Zou, Xi, Zhou, Jin-yong, Wu, Jian, and Wang, Rui-ping
- Subjects
ANALYSIS of variance ,APOPTOSIS ,BIOLOGICAL assay ,BIOPHYSICS ,CELL culture ,CELL cycle ,CELL lines ,COLON tumors ,DOSE-effect relationship in pharmacology ,FLOW cytometry ,HERBAL medicine ,RESEARCH methodology ,CHINESE medicine ,POLYMERASE chain reaction ,RECTUM tumors ,RESEARCH funding ,WESTERN immunoblotting ,REVERSE transcriptase polymerase chain reaction ,DATA analysis software ,IN vitro studies - Abstract
Jianpi Huayu Decoction (JHD), a Chinese medicine formula, is a typical prescription against multiple tumors in the clinical treatment, which can raise quality of life and decrease complications. The aim of this study is to assess the efficacy of JHD against human colorectal carcinoma cells (SW480) and explore its mechanism. MTT assay showed that JHD decreased the cellular viability of SW480 cells in dose-dependent and time-dependent manner. Flow cytometry analysis revealed that JHD induced G0/G1-phase cell cycle arrest in SW480 cells and had a strong apoptosis-inducing effect on SW480 cells. Meanwhile it enhanced the expression of p27, cleaved PARP, cleaved caspase-3, and Bax and decreased the levels of PARP, caspase-3, Bcl-2, CDK2, CDK4, CDK6, cyclin D1, cyclin D2, cyclin D3, and cyclin E1, which was evidenced by RT-qPCR and Western blot analysis. In conclusion, these results indicated that JHD inhibited proliferation in SW480 cells by inducing G0/G1-phase cell cycle arrest and apoptosis, providing a practicaltherapeutic strategy against colorectal cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
50. The effect of Chaiqin Chengqi Decoction (柴芩承气汤) on modulating serum matrix metalloproteinase 9 in patients with severe acute pancreatitis.
- Author
-
Guo, Jia, Xue, Ping, Yang, Xiao-nan, Lin, Zi-qi, Chen, Yan, Jin, Tao, Wu, Wei, Liu, Xu-bao, and Xia, Qing
- Subjects
ADULT respiratory distress syndrome ,MULTIPLE organ failure ,SHOCK (Pathology) ,APACHE (Disease classification system) ,C-reactive protein ,CHI-squared test ,HERBAL medicine ,CHINESE medicine ,METALLOPROTEINS ,PANCREATITIS ,PLACEBOS ,RESEARCH funding ,STATISTICS ,T-test (Statistics) ,DATA analysis ,RANDOMIZED controlled trials ,ACUTE diseases ,DISEASE complications ,DRUG administration ,DRUG dosage ,PREVENTION - Abstract
Objective: To investigate the effect of Chaiqin Chengqi Decoction (柴芩承气汤, CQCQD) on regulating serum matrix metalloproteinase 9 (MMP-9) in patients with severe acute pancreatitis (SAP). Methods: Thirty-five SAP patients hospitalized in West China Hospital from September 1, 2008 to February 28, 2009 were randomly assigned to two groups using a computer-derived random number sequence in a ratio of 1:1, treatment group (18 patients) and the placebo control group (17 patients). The patients in the treatment group were administered with CQCQD by gastric perfusion (50 mL/2 h) and retention enema (200 mL/6 h) for 7 days. The two groups had similar baseline information. The clinical indicators, including the initial Balthazar’s computed tomography (CT) score, acute physiology and chronic health evaluation II (APACHE II) scores on 1st, 3rd, 5th and 7th day, incidences and durations of complications and the serum C-reactive protein (CRP), levels of MMP-9 on the 1st, 3rd, 5th and 7th day, were recorded and compared between the two groups. Results: The serum MMP-9, CRP and the APACHE II scores on the 3rd, 5th and 7th day in the treatment group were lower than those in the control group ( P<0.05). The serum MMP-9 was positively correlated with the APACHE II score on the 1st day ( r=0.430, P=0.01). The durations of acute respiratory distress syndrome (5.4±2.4 vs. 2.9±1.3), acute hepatitis (4.6±0.8 vs. 1.9±0.6) and acute heart failure (3.9±1.6 vs. 1.3±0.6, <0.05) in the control group were longer than those in the treatment group. Conclusion: CQCQD could decrease the serum MMP-9 to relieve the severity of clinical symptoms and prevent the development of multiple organ dysfunction syndrome in patients with SAP. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.